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i 
Abstract 
In recent years there has been a surge in interest concerning high intensity intermittent 
exercise training (HIT) due to its ability to confer rapid notable cardio-metabolic health 
benefits. Specifically, HIT has been shown to improve insulin sensitivity and glycaemic 
control as well as other cardiovascular health factors after just 2 weeks of training 
(typically 6 training sessions).  This thesis investigated the potential therapeutic role 
of HIT training within obese cohorts specifically addressing metabolic health, inclusive 
of inflammatory profiles and glycaemic control. 
 
Data demonstrated that HIT training significantly improved maximal aerobic capacity 
(Chapter 6) over a medium (6 week) training term, however was not successful in 
doing so after shorter-term (2 weeks) training (chapter 5). HIT training induced 
significant up-regulation in M2 macrophage gene expression in adipose tissue after 6 
weeks of training (chapter 6) however did not induce significant improvements in 
plasma inflammatory profile (chapters 5 and 6). Glucose control and body composition 
were unchanged throughout regardless of training programme length.  HIT training 
failed to induce any changes in fat loss, with data to suggest that excess post-exercise 
oxygen consumption (EPOC) contributed minimally as a fat loss mechanism (Chapter 
4). 
 
In conclusion, the findings in this thesis demonstrate that sub-maximal low volume HIT 
training may have positive effects on localised inflammation and aerobic capacity, 
however further work is required in order to ascertain the true therapeutic potential of 
HIT on glucose control and body composition. 
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1CHAPTER 1 
 
 
 
INTRODUCTION 
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1.1 Interval training – A historical perspective 
The subsequent studies within this thesis aimed to profile to the effectiveness of HIT 
type training for improving determinants of metabolic health in pre-clinical populations. 
Within the first experimental chapter (4) this thesis demonstrated that HIT type training 
did not induce prolonged elevation of energy expenditure across a 12 h time course 
and as such was unlikely to contribute significantly to potential changes in body fat 
across the course of a short-term HIT training programme such as that described 
previously (Leggate et al. 2012). Chapter 5 aimed to profile the effectiveness of a 
recently popularised (Little et al. 2011) short term low-volume HIT training protocol for 
improving glycaemic control, inflammatory profile and aerobic capacity within an obese 
cohort. Additionally this chapter utilised a sub-group in order to assess the potential 
effects of reduced training frequency on the aforementioned clinical outcomes. 
Chapter 5 failed to demonstrate any improvements in any measurement parameter in 
either experimental group. The results gave rise to the conjecture that the training 
protocols implemented within the chapter were not effective tools for reducing markers 
associated with cardio-metabolic health risk. The final experimental chapter within this 
thesis aimed to extend findings by previous authors (Larsen et al. 2014) by profiling 
the effectiveness of a novel HIT type intervention on markers associated with 
metabolic disease. Along with glycaemic control, systemic inflammation and aerobic 
capacity, this chapter focussed on adipose tissue, assessing tissue specific 
inflammation at both the RNA and protein levels. Results demonstrated that 6 weeks 
of HIT training significantly improved aerobic capacity, with RNA markers of M2 anti-
inflammatory macrophages being significantly up-regulated. No further changes in 
glycaemic control or inflammation were demonstrated. These data would suggest that 
a protocol with greater volume and/or intensity may be required in to elicit positive 
 3 
 
changes in glucose control and inflammation with cohorts similar to those used within 
this thesis. 
 
Interval training was first described within academic literature by Reindell and 
Roskamm (1959), and later popularised after the Second World War by Emil Zatopek, 
winner of Olympic gold in the 5000 m, 10000 m and marathon during the Helsinki 
games in 1952. Zatopek was reported to have repeated up to 100 x 400 m repetitions 
per day run at a pace close to that of ‘hard-work’, interspersed with 200 m of recovery. 
Furthermore Roger Bannister, the first sub-4-minute miler, employed interval training 
in varying forms 5 days per week almost all year round. Reportedly, Banister’s coach 
preferred the athlete to focus on the quality of the work performed as opposed to 
quantity; significantly reducing the amount of continuous miles run by Bannister. 
 
During the 1960’s research into intermittent exercise grew with the work of Per Olof 
Åstrand and colleagues describing the fundamental physiological responses to 
intermittent exercise. Even at this early stage Åstrand hinted at the potential broader 
benefits of interval exercise stating that “This is of interest not only for the training of 
sportsmen, but also for the rehabilitation of patients…” This early data (Åstrand et al. 
1960a, 1960b; Christensen, Hedman and Saltin 1960) demonstrated that interval 
training at a velocity between critical velocity (the vertical asymptote of the velocity-
time relationship) and velocity at V̇O2max (vV̇O2max - defined as the velocity associated 
with V̇O2max determined by an incremental work test on a treadmill) could elicit V̇O2max 
despite complete rest between 2-3 min hard repetitions. Åstrand considered this one 
of the best forms of interval training to improve V̇O2max since all cardiorespiratory 
parameters were stressed to their maximum. Åstrand (1960a) also demonstrated that 
the mechanical efficiency during intermittent work was not different to that of 
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continuous exercise. This work was extended by the same group to profile shorter 
exercise:rest intervals. Christensen and colleagues (1960) were the first to propose 
very short (10-15 s) interval running at an intensity equivalent to 100 % vV̇O2max, 
interspersed with 10-15 s of recovery. This study profiled the metabolic response to 
such short intervals and demonstrated that a runner, 24 year old Bengt Saltin, with a 
V̇O2max of 67 ml.min.kg-1 reached 99 % V̇O2max in the final intervals of the 30 min 
intermittent exercise session composed of 10-15 s sprints. Sometime later, Karlsson 
and Saltin (1971) published data describing the metabolic response within skeletal 
muscle during high intensity interval work. This group took muscle biopsies following 
each of 5 repetitions of 1 min of exercise at approximately 120 % of the power required 
to reach V̇O2max (pV̇O2max), followed by 5 min of rest. Data showed that creatine 
phosphate was progressively depleted after each repetition with muscle lactate 
reaching 25 mmol.L.kg-1 (wet muscle). This series of early work can be credited with 
being the first to extend understanding of the metabolic consequences of the 
intermittent exercise paradigm. 
 
During the seventies, V̇O2max, and sub-maximal increments, began to be 
systematically measured regularly, with major advancements in training physiology 
coming about through the work of Alois Mader and others who aided in the 
determination of the blood lactate threshold at 4 mmol.L-1 using 5 min stages of 
constant velocity (Mader et al. 1976). The eighties saw the emergence of running 
talents such as Sebastian Coe who performed interval training along with circuit 
training for strength and power gains. During this decade coaches would use specific 
velocities to calibrate interval training without taking into account physiological 
markers. It is now well established that the minimal velocity that elicits V̇O2max in a 
steady state condition is below vV̇O2max and is actually set at between the velocity at 
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the maximal lactate steady state and vV̇O2max, this being defined  as v∆50 (Billat et al. 
2000). 
 
The work of Veronique Billat and colleagues during the nineties and early 2000’s 
began to further explain that improvements in V̇O2max correlated strongly with time 
spent exercising at V̇O2max. One of the best examples of this work compared time 
spent at V̇O2max during both high intensity interval and continuous type exercise (Billat 
et al. 2000). The group hypothesised that continuous running at v∆50 allowed 
participants to remain closer or at V̇O2max for a longer period than intermittent running 
at vV̇O2max, whilst eliciting a similar accumulation of blood lactate. The time spent at 
V̇O2max within an intermittent trial was 8 min (83 % of total time run at vV̇O2max) and 2 
min 42 s for the continuous exercise trial (approximately 50 % of time spent at v∆50).  
 
When comparing blood lactate concentrations, end values averaged 7.4 ± 1.8 and 8.0 
± 1.2 mmol.L-1 for intermittent and continuous exercise respectively, with the values 
not being significantly different from one another. This work clearly demonstrated that 
time spent at V̇O2max was critical for the improvement of aerobic capacity.  
 
An expansive volume of literature exists relating to interval training and aerobic 
capacity with the work of Billat representing a small fraction relevant specifically to 
applied performance physiology. Interestingly this work has a wider relevance to 
health physiology, given the strong association between V̇O2max and the prediction of 
all-cause morbidity and mortality (Carnethon et al. 2003; Chase et al. 2009; Kodama 
et al. 2009; Lee et al. 2010). Interval training with a focus on improving V̇O2max may in 
part act as an achievable intervention for improving health outcomes in pre-clinical 
populations. 
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Those who are overweight and obese represent one such pre-clinical population and 
represent a developing issue globally, with a rapid increase in prevalence resulting in 
a congruent rise in metabolic diseases such as insulin resistance and type 2 diabetes 
mellitus (T2DM) (Danaei et al. 2011). It is clear that lifestyle interventions that are both 
economical and accessible are urgently required in order to prevent and treat the 
growing epidemic.  
 
The core defect underlying the development of type 2 diabetes mellitus (T2DM) is 
skeletal muscle insulin resistance (DeFronzo and Tipathy. 2009). Mechanisms and 
primary contributing factors of insulin resistance are both vast and complex. Evidence 
suggests that physical inactivity may be the principal initiating factor (Thyfault and 
Krogh-Madsen. 2011). Inactivity leads to reduced energy expenditure, which when 
combined with increased energy intake promotes adipose tissue expansion and with 
it the development of obesity and a state of chronic inflammation.  Inflammation has 
been independently implicated in the development of insulin resistance and T2DM 
(Wellen & Hotamsiligil. 2005) and is characterised by abnormal cytokine production, 
increased production of acute phase reactants as well as activation of a network of 
inflammatory signalling pathways (Hotamisligil 2006). Insulin stimulates tyrosine 
phosphorylation of insulin receptor signalling (IRS) proteins, which is a crucial event 
in mediating insulin action and is a significant signalling defect of systemic insulin 
resistance. Inflammatory mediators promote insulin resistance through inhibitory 
serine phosphorylation of IRS-1. IRS-1 serine phosphorylation disrupts insulin-
receptor signalling through several distinct mechanisms, ultimately blocking insulin 
action (Hotamisligil et al. 1996; Zick. 2005).   
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Regular exercise improves insulin sensitivity and is effective in preventing T2DM 
(Goodyear and Kahn. 1998). Traditionally, health oriented physical activity guidelines 
have centred on individuals undertaking moderate intensity, continuous forms of 
exercise on most days of the week (Bull et al.  2010). Given that the most commonly 
cited reason for not participating in physical activity is lack of time, and the recent 
evidence that individuals prefer an intermittent exercise protocol in comparison to 
continuous exercise (Bartlett et al. 2012), it is now timely to consider novel forms of 
exercise that may be more readily adopted. 
 
Recent work suggested that sprint interval training (SIT) training involving a series of 
30 s all out cycle sprints (i.e. Wingate sprints) with 4 min recovery between bouts 
provided an efficient strategy for inducing adaptations comparable to those seen 
following traditional endurance based training (Burgomaster et al. 2005; Gibala et al. 
2006; Burgomaster et al. 2007; Burgomaster et al. 2008; Rakobowchuck et al. 2008; 
Trilk et al. 2010). Furthermore several authors have demonstrated that sprint interval 
SITand HIT may have favourable effects on metabolic control after as few as 6 
sessions. (Burgomaster et al 2006, 2008; Gibala et al. 2006; WislØff et al. 2007; 
Tjonna et al. 2008; Babraj et al. 2009; Haram et al.  2009; Nybo et al. 2010; Richards 
et al. 2010; Whyte et al. 2010; Gaesser and Angadi. 2011; Hood et al. 2011; Little et 
al. 2011; Shepherd et al. 2013). Additionally data demonstrate that reduced-exertion 
sprint based exercise, the most recent variation to high intensity exercise consisting 
of just 20 s sprints, was successful in improving metabolic health and aerobic capacity 
(Metcalfe et al. 2011).  
 
HIT and SIT training are in part characterised through activation of large muscle mass 
and associated with high glycogen breakdown/turnover (Burgomaster et al. 2006). 
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Consequently a greater proportion of muscle fibres require replenishment of their 
carbohydrate stores. It is this high level of glycogen depletion following HIT/SIT that 
may play a pivotal role in the improvement of insulin sensitivity in cohorts at risk of 
metabolic disease. Muscle glycogen availability is inversely related to muscle cell 
membrane GLUT4 content during insulin stimulation (Derave et al. 2000), glycogen 
synthase activity (Jensen et al. 2006), expression of GLUT4 mRNA (Stenberg et al. 
2006) and therefore insulin sensitivity (Derave et al. 2000; Jensen et al. 2006; 
Kawanaka et al. 2000; Laurant et al. 2000; Litherland et al. 2007; Richter et al. 2001). 
It may be suggested therefore that exercise modalities such as SIT and HIT, which 
reduce muscle glycogen levels, are likely to be effective in reducing metabolic disease 
profiles.  
 
It is the aim of this thesis to explore further the paradigm of interval training and how 
best to apply this form of exercise within an obese population. Specifically this thesis 
aims to examine the effects of different high intensity intermittent exercise protocols 
on improving markers of metabolic disease including glucose tolerance, insulin 
sensitivity and inflammation within an obese population.  
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2.1 The development of the high intensity interval training (HIT) paradigm  
Regular endurance training is an effective training strategy to improve health (Fletcher 
et al. 1996). Guidelines recommend 150 min of moderate continuous exercise per 
week in order to maintain a state of good health (Department of Health 2011). This for 
many is an achievable prospect yet for others this time commitment is too high 
rendering typical continuous moderate exercise unattainable. In recent years there 
has been a growth in interest surrounding alternative strategies to gain health benefits 
including aerobic interval training (AIT) sprint interval training (SIT), low-volume high 
intensity interval training (HIT) and reduced exertion HIT training (RE-HIT) which may 
represent novel strategies to induce adaptations normally associated with endurance 
training.  
 
2.1.1 Aerobic interval training 
A form of interval training, known as aerobic interval training (AIT) is an exercise 
variant deemed suitable for de-trained and clinical populations. The work of Talanian 
and colleagues (2007) formed a manageable exercise protocol that looked at the 
broader application of interval training. Healthy women completed a total of thirteen 
days of training. Training consisted of 10 x 4 min intervals at 90 % V̇O2peak separated 
by 2 min recovery. This group (Talanian et al. 2007) demonstrated a 13 % increase in 
V̇O2peak after just 7 sessions of AIT. During a 60 min continuous cycle test, whole body 
fat oxidation was significantly higher at 30 min, 45 min and 60 min after training, 
showing a 36 % increase compared to baseline values. Muscle analysis provided data 
consistent with others (Rodas et al. 2000; Burgomaster et al. 2005, 2006; Gibala et al. 
2006), showing a 20 % increase in maximal citrate synthase (CS) activity after training. 
Furthermore, activity of β-HAD (the rate limiting enzyme of β-Oxidation) increased by 
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32 % after training. Although resting muscle glycogen content was unaffected by 
training the net muscle glycogen utilisation was decreased by 12 % after 60 min of 
cycling, with net phosphocreatine (PCr) degradation significantly decreased by 40 % 
after HIT training. Talanian et al (2007) were the first to demonstrate that interval 
training at an intensity equivalent to 90 % V̇O2peak, an intermediate between classical 
sub-maximal and sprint training paradigms, was able to increase both V̇O2peak as well 
as markers of oxidative and glycolytic potential. This was based on increases in β-
HAD (32%) and CS (20%). Despite presenting novel findings they failed to include a 
moderate intensity control group and as such do not definitively define AIT exercise 
as being of greater benefit compared to matched continuous moderate training in 
improving aerobic capacity and muscle metabolism. 
 
WislØff et al (2007) addressed the use of AIT (referred to as HIT in publication) training 
within a patient population. Specifically patients with post infarction heart failure 
(ejection fraction < 40 %) were assigned to a HIT group, a moderate continuous 
training (MCT) group or a non-exercising control group. The HIT training was carried 
out 3 x per week and consisted of 4 x 4 min uphill walking intervals at 90 % - 95 % 
peak heart rate (HRpeak) separated by 3 min recovery. After twelve weeks of exercise 
training V̇O2peak increased by 46 % and 14 % for AIT and continuous groups 
respectively. AIT also improved work economy to a greater extent than continuous 
training, evidenced by a 15 % reduction in oxygen cost, reduced heart rate (HR) and 
blood lactate at any given submaximal walking speed. Protein levels of peroxisome 
proliferator-activated receptor gamma co-activator 1-alpha (PGC-1α) increased by 47 
% in the HIT group and correlated highly with improvements in V̇O2max (r = 0.71). This 
study (WislØff et al. 2007) demonstrated that AIT was feasible in those with clinical 
pathologies. As with the testing of any clinical population, the measurement of aerobic 
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capacity can often provide falsely low values prior to training and then more accurate 
elevated values after an exercise intervention. All but 2 individuals within the WislØff 
study met the criteria for true maximal oxygen uptake as defined by a levelling off of 
oxygen uptake despite increases in workload and an RER above 1.05. As such the 
data can be deemed robust. The study is limited by low numbers, however as a proof 
of concept design this work acted as a vehicle for further investigation into the clinical 
application of AIT. 
 
TjØnna and colleagues (2008) extended previous work by the same group using an 
identical exercise regimen, this time in a cohort diagnosed with metabolic syndrome. 
After sixteen weeks, AIT reduced factors of the metabolic syndrome more than a 
continuous moderate exercise group. At the end of the AIT training period 46 % of 
individuals were no longer diagnosed with the metabolic syndrome, compared to the 
37 % following continuous exercise. Insulin receptor (IR) phosphorylation was 
increased to a greater extent following AIT compared with any other intervention. This 
is particularly pertinent given that the measurement of IR phosphorylation is a 
reflection of peripheral insulin sensitivity in obese and T2DM patients. This study 
(TjØnna et al. 2008) along with further work from the same group in a rat model (Haram 
et al. 2009) provided clear justification for further investigation into the application of 
AIT based training across a spectra of chronic disease states. 
 
With relevance to the current thesis, Leggate and colleagues (2012) replicated a 
previous AIT protocol (Talanian et al. 2007) within an overweight and obese cohort. 
After just 2 weeks (6 sessions) of training data demonstrated a significant reduction in 
inflammatory profile specifically in plasma and adipose tissue. These data (Leggate et 
al. 2012) were the first to establish that sub-maximal interval training could potentiate 
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health improvement via improved inflammatory profile and aerobic capacity. Clearly 
from the data provided by this group (Leggate et al. 2012) further work is warranted in 
order to ascertain if exercise volume can be further reduced whilst still instigating 
health improvements within the pre-clinical population and is reflected in this thesis. 
 
2.1.2 Sprint interval training 
The most utilised high intensity protocol within the literature consists of ‘all-out’ 
repeated 30 s ‘SIT’ sprints. Sprints are repeated 4-6 times with each bout separated 
by ~ 4 min of recovery. Typically a braking force of 0.075 kg per kg of body mass is 
applied during the 30 s cycle sprint, with this force reduced or removed entirely during 
recovery. 
 
MacDougall and colleagues (1998) examined aerobic and anaerobic components of 
fitness in healthy males, focusing on glycolytic and oxidative enzyme activity following 
7 weeks (3 x per week) of SIT exercise training. After training, both peak power output 
and total work over 30 s significantly increased. V̇O2max increased from 3.73 ± 0.13 to 
4.01 ± 0.08 L.min-1. Activity increases in hexokinase, glycogen phosphorylase, 
phosphofructokinase, lactate dehydrogenase, CS, succinate dehydrogenate, malate 
dehydrogenase and 3-hydroxyacyl-CoA-dehydrogenase were indicative of increased 
oxidative and glycolytic potential.  
 
Rodas et al (2000) utilised a more manageable protocol based on greater recovery 
periods. This group presented similar findings to that of MacDougall and colleagues 
(1998). Two weeks of training consisted of mixed sessions of 15 s all out reps with 45 
s rest periods and 30 s SIT reps with 12 min rest periods. The initial training session 
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consisted of 2 bouts of 15 s and 7 bouts of 30 s. Bouts were increased by 1 every 2 
training sessions. Data (Rodas et al. 2000) demonstrated that after training, muscle 
PCr was significantly increased by 31 % and muscle glycogen by 32 %. Following 2 
weeks of training lactate accumulation was significantly lower at the end of a 30 s ‘all 
out’ performance test when compared against pre-training values. Performance gains 
were significantly increased following training with maximum power output increasing 
by 10 % and V̇O2max by 11 %. Despite demonstrating beneficial oxidative and glycolytic 
responses this study lacked statistical power given the small sample size (n = 5) and 
as such data should be viewed with caution especially with respect to performance 
gains. Further, despite the high intensity repetitions being of short duration the overall 
training volume was high. This time commitment may not pose an attractive prospect 
for many given that ‘lack of time’ is cited as being one of the biggest barriers to exercise 
(Leslie et al. 1999; Stutts et al. 2002; Trost et al. 2002) and would suggest a need for 
similar exercise at a much reduced volume. 
 
In the mid 2000’s Gibala and colleagues published a body of work looking towards a 
significantly reduced volume of exercise to elicit similar metabolic responses to that of 
regular continuous moderate exercise. This work profiled the metabolic responses to 
low volume SIT. The first paper in a series of publications, now regarded as being 
central to our understanding of SIT came from Burgomaster et al (2005). Burgomaster 
examined the effects of 6 sessions of SIT over 2 weeks on muscle oxidative potential, 
V̇O2peak and cycling endurance time to fatigue in recreationally active participants. 
Participants were assigned to either an exercising or non-exercising group. Results 
demonstrated a 100 % increase in cycle endurance time to fatigue compared with 
baseline in the exercising group. SIT training did not improve V̇O2peak nor were there 
any changes in power output between the first and last training sessions. Maximal 
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activity of CS increased by 38 % after training with resting muscle glycogen increasing 
by 26 % after training which is comparable to earlier work (MacDougall et al. 1998; 
Rodas et al. 2000) despite a significantly reduced overall training volume. The 
increase in muscle oxidative potential was comparable to that reported following 6-7 
days of traditional endurance exercise training (Chesley et al. 1996; Spina et al. 1996). 
 
Building on the finding of improved oxidative capacity following low volume SIT 
exercise, Burgomaster et al (2006) revealed time taken to complete a 250 kJ time trial 
decreased by 9.6 % following SIT training which was further reflected by a 5.4 % 
increase in average power output. In agreement with their previous work (Burgomaster 
et al. 2005) V̇O2max did not increase after training, differing from the results obtained 
by MacDougall et al (1998) and Rodas et al (2000) after using SIT training, suggesting 
a yet to be elucidated optimal intensity / duration intercept which must be achieved in 
order to improve aerobic capacity. Burgomaster provided the first evidence that SIT 
improved exercise performance during a time trial scenario and further validated 
previous findings (Burgomaster et al. 2005) that skeletal muscle oxidative capacity 
may be enhanced by a brief 2 week training period equivalent to only 16 min of high 
intensity work. 
 
Gibala et al. (2006) later established that following SIT training), the time required to 
complete a 750 kJ time trial significantly decreased by 10.1 % versus  a decrease of 
7.5 % following endurance training (consisting of 90 min - 120 min of continuous 
cycling 3 x per week). Mean power output during a time trial increased to a greater 
degree following SIT (22 W) compared to endurance training (13 W). The maximal 
activity of mitochondrial oxidative enzymes (cytochrome oxidase and its specific 
subunits II and IV) increased after SIT training despite no differences between groups 
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for muscle oxidative capacity. This work (Gibala et al. 2006) was the first to directly 
demonstrate that 6 sessions of low volume SIT over 2 weeks induced comparable 
improvements to traditional high volume endurance training in muscle oxidative 
capacity and exercise capacity despite a 90 % reduced overall training volume 
however changes in V̇O2max were not reported making it impossible to determine 
changes in aerobic capacity.  By proposing SIT training as an efficient strategy for 
inducing performance benefits Gibala and colleagues provided a catalyst for the recent 
intensification of research into the area of high intensity exercise. 
 
Extending the SIT training model beyond the classic 2 week period through to 6 weeks 
Burgomaster et al (2008) compared SIT training with exercise recommended by public 
health guidance (American College of Sports Medicine 1998) making the study one of 
the first to focus on the potential for SIT training to re-inform exercise prescription and 
policy. The SIT training utilised was identical to that used previously (Burgomaster et 
al. 2005, 2006; Gibala et al. 2006). Endurance exercise consisted of 40 min – 60 min 
of continuous cycling at 65 % V̇O2peak (American College of Sports Medicine 1998). 
Following training, V̇O2peak significantly increased with no differences between groups 
despite a 90 % lower training volume in the SIT group. Mean power output increased 
only following SIT training by 7 %. After training there were no differences between 
groups in oxygen uptake during 60 min constant load cycling, RER values during 
constant load cycling, total fat or carbohydrate oxidation with all parameters improving 
after 6 weeks of training.  Here Burgomaster et al. (2008) demonstrated that SIT was 
indeed a time efficient strategy to induce changes in selective markers of whole body 
and skeletal muscle metabolism with positive gains being comparable to those of high 
volume moderate intensity exercise. This work demonstrated that the potential health 
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benefits gained via government prescribed exercise may also be achieved with 
significantly lower training volumes through SIT.   
 
Early SIT literature failed to clarify the exercises wider application specifically its 
deployment within clinical populations and associations with health improvements. 
Later work from Babraj et al (2009) demonstrated 6 sessions of SIT over a 2 week 
period reduced area under the plasma glucose, insulin and free fatty acid (FFA) 
concentration curves (AUC) by 12 %, 37 % and 26 % respectively in a group of young 
sedentary males following an OGTT test, further supporting the notion that SIT may 
be used as a novel strategy to reduce metabolic risk factors.  
 
Whyte et al (2010) described reductions in waist circumference of 1.4 cm as well as a 
significant reduction of 15 % in 2 h insulin AUC following 2 weeks of SIT in an obese 
cohort. Significant improvements in V̇O2max were demonstrated following 2 weeks of 
training. The authors attributed significant improvements to a relatively low level of 
baseline fitness within the cohort. This may be unlikely given that baseline aerobic 
capacity neither positively nor negatively associates with gains in exercise training 
induced maximal aerobic power (Hautala et al. 2006; Timmons 2011). This is still a 
contentious issue given recent work demonstrating a fairly weak yet significant 
Pearson correlation of -0.4 between basal V̇O2max and % improvement in aerobic 
capacity following 2 weeks of SIT (Astorino, Schubert 2014). Changes in V̇O2max 
reported by Whyte and colleagues (2010) are confounded by a lack of control group 
and are further attributed to a possible “learning effect”. This may have been reduced 
had at least 2 baseline tests been conducted. Equally, in line with current 
understanding, it is most probable that peripheral adaptations may be almost 
exclusively responsible for improved exercise capacity commonly witnessed after 
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short SIT interventions (Gibala & McGee 2008). Similar adaptations were 
demonstrated by Richards et al (2010) whom following the identical training 
programme (Burgomaster et al. 2005) demonstrated via hyper-insulinaemic 
euglycaemic clamp, significant increases in insulin sensitivity despite no significant 
changes in basal glucose and insulin concentrations. Additionally, reduced glucose 
and insulin AUC as well as improved insulin sensitivity as assessed via OGTT, has 
been shown after 6 weeks of SIT training (Shepherd et al. 2013), with improvements 
being similar to high volume continuous moderate cycling. The data described above 
(Babraj et al. 2009; Richards et al. 2010; Whyte et al. 2010; Shepherd et al. 2013) 
demonstrated the therapeutic potential for high intensity exercise to improve the 
wellbeing of individuals at risk of developing metabolic disease. 
 
For more than a decade, the regulation of energy provision during repeated bouts of 
maximal isokinetic cycling such as SIT has been examined (Jones et al. 
1985; McCartney et al. 1986, Putman et al. 1995, Spriet et al. 1989, Trump et al. 1996). 
During sprint exercise, power outputs are elicited in excess of 2 to 3 times that at which 
V̇O2max is achieved. To meet the maximal demand for ATP, the majority of energy for 
short maximal exercise is derived via substrate phosphorylation from PCr hydrolysis 
and glycolysis (Jones et al. 1985, Karlsson 1971, Margaria, Edwards and Dill. 1933). 
However, studies using intermittent exercise consisting of 2 to 4 bouts of 30 s of 
maximal cycling separated by 4 min of rest have demonstrated that there is a 
progressive shift to oxidative metabolism in later bouts (Bogdanis et al. 1996; Putman 
et al. 1995, Spriet et al. 1989, Trump et al. 1996). It is not surprising therefore, that 
aerobic capacity has been shown to significantly increase following low volume HIT 
training as explored within the current thesis (Chapter 6) 
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In addition, significant lactate accumulation occurs in the first bout compared with the 
third and fourth bouts, where lactate accumulation is negligible (McCartney et al. 
1986, Putman et al. 1995, Spriet et al. 1989). Reduced flux through the glycolytic 
pathway and a greater degree of activation of pyruvate dehydrogenase before a third 
bout is accompanied by an increase in oxygen uptake, which contributes to reduced 
accumulation of lactate and increased oxidation of pyruvate (Putman et al. 1995). It is 
likely therefore that exercise constructs consisting of 5-10 bouts as demonstrated 
within this thesis will be defined by similar metabolic pathways. Associated with a 
reduction in lactate accumulation is an increase in oxidative phosphorylation in a third 
bout of SIT compared with the first. With this in mind, a rationale develops for the 
improvement of aerobic and oxidative capacity following 4-6 sprints in as little as 2 
weeks as will be investigated further within this work. 
 
During maximal sprint exercise, glycogen is the primary substrate, with extracellular 
glucose providing ∼2–3 % of the total (Katz et al. 1986; Putman et al. 1995). Therefore, 
glycogen phosphorylase catalyses the rate-limiting step in glycogenolysis and sets the 
upper limit for the rates of glycolysis. This mechanism is particularly pertinent to the 
obese / pre-diabetic cohort. Depleting glycogen stores via HIT type training may allow 
for an increased ‘sink’ or ‘capacity’ for exogenous glucose intake. With this in mind this 
may begin to rationalise the use of the HIT training modality within those at risk of 
hyperglycaemia.  
 
2.1.3 High intensity interval training  
Of critical relevance to this thesis is HIT training. This training modality is composed 
of ~1 - 3 min high intensity intervals separated by matched or reduced recovery times. 
 20 
 
The workload is often set at 80 % - 100 % V̇O2max and performed intermittently over 
10-30 min with a high number of repetitions completed.  Previously many HIT models 
have been restricted to young and relatively healthy participants; with much less 
known about the application of HIT based training within a sedentary or overweight 
population, who may be at a greater risk of developing disease (Trost et al. 2002).  In 
the first of a series of studies, Hood et al (2011) explored the effectiveness of a novel 
HIT intervention within a sedentary but otherwise healthy population. An exercise 
model consisting of 10 x 1 min bouts at ~ 95 % of heart rate reserve (HRR) with 1 min 
recovery was completed 3 times per week for 2 weeks. Data revealed comparable 
adaptations in mitochondrial enzymes to those achieved following 6 weeks of SIT 
based training (Burgomaster et al. 2007) and high volume endurance exercise 
(Pilegaard et al. 2003). Fasting insulin showed a marked decrease of 16 % after 
training with insulin sensitivity calculated by homeostasis model assessment (HOMA) 
improving by 35 %. In spite of a low sample size, this study showed for the first time 
that with a low total exercise volume and training time commitment, a novel HIT 
intervention was successful in improving glycaemic control within a sedentary 
population.  
 
Given the striking results obtained by Hood and colleagues (2011), Little and 
colleagues (2011) utilised the identical training protocol to extend its application within 
a group of T2DM patients. Before and after the training period continuous glucose 
monitoring was employed over a 24 h period to assess average blood glucose 
concentrations and post-prandial hyperglycaemic excursions under a standardised 
diet. Training induced a marked 13 % reduction in average blood glucose 
concentration over 24 h, further reflected in reduced 24 h blood glucose AUC.  Equally, 
the sum of 3 h postprandial AUC was significantly lower after training. Although 
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reducing fasting hyperglycaemia is a significant aspect of T2D treatment, evidence 
suggests that lowering postprandial hyperglycaemia is just as important for achieving 
adequate glycated haemoglobin (HbA1c) levels (Woerle et al. 2007). 
 
HbA1c is a form of haemoglobin that is measured primarily to identify average blood 
glucose concentrations over an extended period of time. When circulating levels of 
blood glucose are elevated glucose molecules attach to haemoglobin in red blood 
cells. The amount of glucose that binds to the haemoglobin is proportional to the length 
of time an individual spends in hyperglycaemia. Once haemoglobin is glycated it 
remains in this form and therefore a build-up within the red blood cell reflects the 
average level of glucose the cell has been exposed to over its life-course. HbA1c is 
reflective of an individuals blood glucose levels during a previous 1 – 3 month period.  
 
Compared with fasting glucose, HbA1c has several advantages as a diagnostic test; 
it has higher repeatability (Selvin et al. 2007), can be assessed in the non-fasted state, 
is the preferred test for monitoring glucose control (American Diabetes Association. 
2009). Elevated HbA1c levels are a risk factor for macrovascular disease (Selvin et al. 
2010).  
 
As demonstrated previously following high intensity training (Gibala et al. 2006; Little 
et al. 2011), maximal activity of mitochondrial enzymes was elevated following training 
with skeletal muscle mitochondrial protein content also showing significant elevations. 
Total GLUT4 protein was increased by ~ 369% which was greater than that 
demonstrated by Hood et al (2011) within a sedentary population. Functional 
performance was increased with the maximal workload achieved during a ramp cycling 
test improved by 10 % following training, with HR and rate of perceived exertion (RPE) 
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reducing significantly as a consequence of training. These pilot data demonstrated 
that low volume HIT may rapidly reduce hyperglycaemia and increase skeletal muscle 
oxidative capacity in patients with T2DM. Notably these improvements were achieved 
following a total time commitment of 75 min per week, which was half of the 150 min 
moderate weekly exercise previously advised (Bull et al. 2010). The work described 
here (Little et al. 2011) did not include a moderate intensity control group by which to 
compare the benefits of HIT based training over continuous. 
 
Research manipulating HIT training is ever increasing and it is probable that this 
modality of training is the most achievable for the sedentary and clinical populations 
when performed at sub-maximal intensities and when recovery time is adequate.  
 
2.1.4 Reduced exertion high intensity intermittent training 
The mechanisms underpinning improvements in metabolic control following high 
intensity based training are yet to be fully elucidated. The work of Babraj et al (2009) 
and others (Whyte et al. 2010) suggested that high levels of glycogen depletion 
observed during the classical 30 s SIT protocol may play an important role in mediating 
improvements in insulin sensitivity following high intensity training by providing a ‘sink’ 
for glucose disposal. This theory is bolstered by the work of Horowitz et al (2005) who 
demonstrated that exercise induced energy deficit attenuated a reduction in 
carbohydrate oxidation 24 h after exercise. If indeed muscle glycogen depletion did 
regulate insulin sensitivity then exercise protocols that reduce muscle glycogen 
concentration should be effective in improving glycaemic control. The 30 s SIT sprint 
protocol such as that utilised by Burgomaster and colleagues (2005) has been shown 
to reduce muscle glycogen stores by up to 30 % (Esbjornsson-Liljedahl et al. 1999; 
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Parolin et al. 1999; Esbjornsson-Liljedahl et al. 2002). According to the work of Parolin 
et al (1999) glycogenolysis is only activated during the first 15 s of the first sprint and 
is then attenuated in the final 15 s. The activation of glycogenolysis is seemingly further 
inhibited in repeated sprints. This suggests that the classic SIT model may be 
unnecessarily demanding for participants as similar glycogen depletion may be 
achieved in shorter sprint formats, making the exercise more applicable to sedentary 
and clinical cohorts. The work of Metcalfe et al (2011) worked towards identifying a 
minimal amount of exercise required for improving parameters of metabolic health. 
Healthy but sedentary participants underwent a 6 week RE-HIT training consisting of 
1 (1st session) or 2 (all other sessions) all-out cycling sprints with sprint bouts 
separated by low intensity cycling at 60 W.  The duration of sprints increased from 10 
s in week 1, to 15 s in weeks 2 and 3 and 20 s in the final 3 weeks with no sessions 
lasting longer than 10 min including warm up and cool down. RE-HIT training 
increased V̇O2peak by ~ 15 %. Of critical importance however was a significant 28 % 
improvement in insulin sensitivity in participants following RE-HIT training with this 
magnitude of change being comparable with responses to 2 weeks of classic SIT 
training in both active (Babraj et al. 2009; Richards et al. 2010) and obese (Whyte et 
al. 2010) individuals. The work of Metcalfe et al (2011) demonstrated for the first time 
that the volume of the classic 30 s SIT protocol could be substantially reduced whilst 
still improving metabolic health and aerobic capacity. Further replication of this 
protocol within in a diabetic population is required in order to ascertain if the increases 
in potential health benefits are as marked. Although not directly defined within the 
study, the authors concede the potential for ‘non-responders’ to lie within the data set, 
suggest it would be logical for RE-HIT work to be repeated with a larger sample size. 
This would allow comparisons to be made to other high intensity protocol used within 
the same population (Little et al. 2011). 
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The application of high intensity training within clinical populations is still a relatively 
new paradigm. Evidence clearly suggests that for insulin resistant and T2DM 
populations low volume high intensity work may prove as beneficial as high volume 
continuous moderate exercise from both a health and time saving perspective. There 
is a great deal of work still to be done in order to elucidate the mechanisms through 
which metabolic health is improved following HIT exercise as well as working towards 
a true ‘minimum’ in terms of the total exercise stimulus necessary to improve 
fundamental health markers and co-morbidities of disease. For a summary of notable 
high intensity interventions please refer to reference table (A) within appendix 1. 
 
2.2 Glucose regulation – An overview 
The ultimate purpose of glucose homeostasis is to provide sugar to the brain (Unger, 
1991; Cryer, Gerich. 1985). Neuronal tissues lack the ability to synthesise ketone 
bodies and oxidise their own amino acids or fatty acids without undergoing adverse 
structural and functional changes (Auer, 1986). Therefore provision of free glucose for 
neuronal oxidation is essential for survival. Hypoglycaemia leads to altered states of 
consciousness and can lead to death. Secondly the maintenance of euglycaemia is 
important for the integrity of proteins throughout the body. Prolonged hyperglycaemia 
leads to excessive glycosylation of proteins, changing their structure and function, 
which eventually effects every organ system in the body.  
 
Glucose can be produced from multiple sources i.e. from fats, proteins via 
gluconeogenesis; and from the muscle and liver via glycogenolysis. Most of the bodies 
energy reserve is stored as fat (DeFronzo, Ferrannini, 1995). Glucose is also stored 
as glycogen. Breakdown of glycogen stores from the liver results in a ready supply of 
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glucose for the brain and other tissues with the need for free glucose and is the primary 
energy source in rested conditions. Muscle glycogen serves as a local source of 
glucose as muscle lacks glucose-6-phosphatase and cannot release free glucose into 
the circulation. Proteins serve as a source of substrates for gluconeogenesis (Gerich, 
Campbell, 1988). Proteins when necessary are broken down to glucose via 
gluconeogenesis by the liver and kidney (Owen et al. 1969). The body protects its 
protein supply given that excessive protein breakdown can lead to cell death. Protein 
breakdown is often witnessed during prolonged fasting. 
 
Under standard nutritional conditions the liver contains 70 g of glycogen which acts as 
an efficient storage form of glucose. During fasting, glycogen phosphorylase initiates 
glycogen breakdown by cleaving a single glucose-1-phosphate which is converted 
then to glucose-6-phosphate by a de-branching enzyme, Glucose-6-phosphatase then 
converts glucose-6-phosphate to free glucose. During fasting, glycogen is depleted at 
a rate of 9 % an hour. When fasting exceeds 8 hours, gluconeogenesis progressively 
replaces glycogenolysis to preserve glycogen stores. 
 
As hepatic glycogen decreases blood glucose levels fall as does insulin secretion. A 
decrease in plasma insulin leads to an increase in glucagon secretion, mobilisation of 
gluconeogeneic precorsours and free fatty acids, and increased hepatic 
gluconeogenesis. Gluconeogenesis requires a total of 12 ATPs; 2 in the form of 
guanosine diphosphate (GDP), four in the form of ATP, and six in the form of NADH. 
The first of these reactions includes conversion of pyruvate to oxaloacetate to 
phosphoenolpyruvate. The second of these reactions is the conversion of fructose-1,6-
bisphosphate to fructose-6-phosphate, which represents the rate-limiting reaction for 
gluconeogenesis. The final reaction is the conversion of glucose-6-phosphate to free 
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glucose, which is necessary for glucose to enter the plasma and is unique to the 
hepatocyte. Following a 10-hour fast, gluconeogenesis accounts for 70% of total 
hepatic glucose production. 
 
Gluconeogenesis is regulated by the pancreatic hormonal milieu, intracellular 
substrate levels, fatty acid levels, counter-regulatory hormones, and the central 
nervous system. Hepatic glucose production is highly responsive to insulin. Half-
maximal suppression of glucose production occurs at insulin levels of 25 mU.ml-1, 
whereas half-maximal stimulation of glucose utilisation occurs at insulin levels of 50 
mU.ml-1 (Rizza et al. 1981). A rise in insulin secretion of 5 to 10 mU.ml-1 results in a 
marked decline in hepatic glucose output (Cahill, 1970). Insulin decreases 
gluconeogenesis by decreasing intracellular cyclic adenosine monophosphate (cAMP) 
levels, which inhibits phosphorylation of enzymes. Insulin also inhibits hepatic glucose 
production indirectly by restraining lipolysis and proteolysis systemically, which 
reduces delivery of glucose precursors to the liver (DeFronzo, Bonadonna, Ferrannini, 
1992; DeFronzo, 1988). 
 
Glucagon has a potent effect on hepatic glucose production by stimulating both 
glycogenolysis and gluconeogenesis, and it increases glucose output within minutes. 
Glucagon’s effects on gluconeogenesis are persistent, whereas its effects on 
glycogenolysis are short-lived (Gerich, Campbell, 1988). Glucagon stimulates 
gluconeogenesis by increasing intracellular cAMP levels. Increased hepatic glucose 
production, in turn, results in suppression of glucagon secretion (Gerich, Charles, 
Grodsky, 1976). 
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Counter-regulatory hormones such as cortisol, growth hormone, thyroid hormones, 
catecholamines, and angiotensin II prevent hypoglycaemia by stimulating hepatic 
glucose production. Epinephrine promotes glycogenolysis, whereas cortisol promotes 
gluconeogenesis (Gann, Foster, 1999). The actions of norepinephrine and angiotensin 
II are mediated by the intracellular signals of phosphatidylinositol and calcium to 
promote glycogenolysis (Coffee, 1998; Gann, Foster, 1999). Cortisol and epinephrine 
also limit pyruvate use, allowing it to be converted to free glucose. The central nervous 
system modulates hepatic glucose production via parasympathetic fibres to the liver 
(DeFronzo, Ferrannini, 1995; Shimazu, 1987). Hypoglyceamia stimulates hepatic 
glucose production via sensors in the hpothalmic region of the brain, which activate 
oxaloacetate in the tricarboxylic acid cycle and directly contribute hepatic 
glycogenolysis via sympathetic fibers to the liver (DeFronzo, Ferrannini, 1987; 
DeFronzo, Ferrannini, Hendler, 1983). 
 
Humans require a constant source of energy, most of which is derived from oxidation 
of glucose. First, glucose must enter the cell via glucose transporters. Five glucose 
transports have been identified (GLUT 1 through to GLUT 5), of which GLUT 4 has the 
strongest association to the current thesis. GLUT 4 is an insulin-dependent transporter 
for muscle and adipose tissue. In the basal state most GLUT 4 transporters are not 
located on the membrane but in intracellular vesicles. Insulin causes a translocation of 
GLUT 4 from intracellular vesicles to the cell membrane. Insulin also augments GLUT 
4 activity; therefore muscle and adipose tissue glucose clearance rates increase 10-
fold with increases in plasma insulin levels (DeFrozo, Bonadonna, Ferrannini, 1992; 
Birnbaum, 1992; Klip et al, 1994; Stephens, Pilch, 1995; DeFronzo et al. 1985). 
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Having entered the cell, glucose is oxidized into energy via the Embden-Myerhof 
glycolytic pathway. Glycolysis occurs in the cytosol of all cells and consists of 10 steps 
that convert 1 mole of glucose into 2 moles of ATP, 2 moles of NADH, and 2 moles of 
pyruvate. ATP is utilised for cellular energy, whereas NADH and pyruvate provide 
substrates for other energy-producing reactions. Glycolysis represents the major 
source of energy (ATP) in cells that lack mitochondria (e.g., erythrocytes) and for cells 
functioning under anaerobic conditions (e.g., contracting muscle). 
 
The rate-limiting step of glycolysis is the conversion of fructose-6-phosphate to 
fructose-1,6-bisphosphate. This step is considered irreversible. The other two 
irreversible steps are the conversion of glucose to glucose-6-phosphate by 
hexokinase/glucokinase and the conversion of phosphoenolpyruvate to pyruvate by 
pyruvate kinase. These three reactions are significant because they are the major 
obstacles that must be overcome in the formation of glucose during gluconeogenic 
reactions. 
 
When there is an adequate supply of oxygen to tissues, the overall reaction for the 
glycolytic pathway ends in pyruvate, which is then converted to acetyl CoA, which 
enters the tricarboxylic acid (TCA) cycle. Approximately 90 % of the potential energy 
from glucose oxidation is available in the form of pyruvate. The TCA cycle nets an 
additional 36 moles of ATP for every mole of glucose. Under anaerobic conditions the 
cells rely on glycolysis for ATP, and pyruvate is converted to lactate. Conversion of 
pyruvate to lactate regenerates cofactors needed for glycolysis which is particularly 
pertinent to the current thesis and the source of energy provision required for HIT type 
training. 
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2.3 Obesity, adipose tissue and inflammation 
Adipose tissue is accepted as being a complex endocrine organ (Trayhurn and Beattie 
2001). It is composed of several cell types with approximately 50 % of adipose tissue 
being composed of adipocytes with the remainder made up of blood cells, endothelial 
cells, adipose tissue precursors and macrophages (Compher and Badellino 2008). 
Excess adiposity leads to a marked secretion of adipokines including the inflammatory 
cytokines and several growth factors growth factors. As the largest endocrine organ in 
the human body (Trayhurn 2005) adipose tissue is able to produce and secrete over 
75 inflammatory proteins (Wood et al. 2009) with augmented production of interleukin-
6 (IL-6), tumour necrosis factor-alpha (TNF-α) and intercellular adhesion molecule -1 
(ICAM-1) being noted in the obese population, in comparison to lean individuals 
(Hotamisligil et al. 1995; Kern et al. 1995; Bosanska et al. 2010). Increased adiposity, 
with concomitant rises in inflammatory cytokine production contributes to a chronic 
state of inflammation which promotes metabolic disorders (Maachi et al. 2004) 
including insulin resistance, the metabolic syndrome and T2DM (Shoelson et al. 2006) 
(Figure 2.1).  
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Figure 2.1 - Obesity induced changes in adipokine secretion and the development of 
insulin resistance. Expansion of adipose tissue leads to increased 
macrophage infiltration and inflammation with enhanced production of 
pro-inflammatory cytokines (Adapted from Galic et al. 2010).  
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2.4 Mechanisms of increased inflammation in adipose tissue 
Adipocytes are both the source and the target of inflammatory signals (Weisberg et al. 
2003; Cancello et al. 2005). Macrophages are mononuclear phagocytes known to 
infiltrate adipose tissue, residing primarily in the stromal vascular fraction (Weisberg 
et al. 2003; Xu et al. 2003). Once resident within adipose tissue, macrophages release 
pro-inflammatory cytokines such as TNF-α, IL-6 and plasminogen activation inhibitor 
(PAI-1) (Gordon 1998). Weisberg and colleagues (2003) demonstrated that 
macrophage accumulation in adipose tissue is directly proportional to the measures 
of adiposity in humans and is significantly higher in the obese compared to lean. The 
same group (Weisberg et al. 2003) estimated that the percentage of macrophages in 
adipose tissue ranged from under 10 % in lean humans, to approximately 40 % in 
obese humans.  
 
Adipocyte size as opposed to overall obesity may act as a trigger for macrophage 
infiltration. New, smaller subcutaneous adipocytes act as a sink or buffer, absorbing 
FFA and triacylglycerol (TAG) in the postprandial period. Once these cells have 
reached an upper threshold, in which they are no longer able to accommodate storage, 
then preferential storage within visceral adipocytes is engaged (Skurk et al. 2007). As 
adipocytes grow larger they become dysfunctional, with abdominal adipose mass 
positively correlated with macrophage infiltration (Curat et al. 2004; Tchoukalova et al. 
2004). This is confirmed by data showing that adipocyte hypertrophy in the rat model 
is coincident with macrophage recruitment and activation as well as inflammation 
within adipose tissue (Cinti et al. 2005).  
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Adipocyte size is an important determinant in the release of cytokines, with IL-6, TNF-
α, monocyte chemo-attractant protein (MCP-1), and interleukin 1 (IL-1) found in the 
highest concentrations in the largest adipocytes (Skurk et al. 2007). This is likely due 
a greater mean surface area and cell volume. It has been proposed previously that 
hypoxia may occur in areas within adipose tissue in obesity as a result of adipocyte 
hypertrophy (Wood et al. 2009). Adipocyte hypertrophy compromises oxygen supply 
from the vasculature, and thereby initiates the inflammatory response through the 
recruitment of the transcription factor hypoxic inducible factor 1 (HIF-1) (Trayhurn and 
Wood 2004). Hypoxia also induces inflammatory responses in macrophages and 
inhibits differentiation of pre-adipocytes (Lewis et al. 1999; Oda et al. 2006; Ye et al. 
2007). Collectively there is strong evidence to suggest that cellular hypoxia as a result 
of adipose tissue expansion may be a significant contributor to adipose tissue 
inflammation. 
 
Huang et al (2001) demonstrated that MCP-1 is an essential signal for macrophage 
activation and recruitment, suggesting this chemokine may be the most likely 
candidate for the stimulation of macrophage recruitment. Additionally Xu et al (2003) 
showed that increased expression of MCP-1 in adipose tissue preceded insulin 
resistance in obese mice, strengthening the suggestion of a causative role of this 
chemokine in macrophage infiltration.  
 
As well as adipose tissue volume and adipocyte size, cytokine levels may be 
influenced by fatty acid composition within the diet as demonstrated by Garcia-
Escobar and colleagues (2010), who showed that rat adipocytes release greater 
concentrations of IL-6 following the consumption of a diet high in fatty acids as 
compared against mice fed on saturated or polyunsaturated fatty acid diets. This 
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further demonstrates that inflammatory regulation is likely to be moderated by more 
than one single factor with one such factor being related to nutrition.  
 
2.5 Subcutaneous and visceral adipose tissue 
Increasing visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) are 
independently regarded as risk factors for insulin resistance and T2DM. Around 80 % 
of all body fat is located in subcutaneous areas (Arner 1997). In contrast VAT makes 
up only 10 % - 20 % of total fat in men and 5 % - 8 % in women (Wajchenberg 2000). 
 
When the storage capacity of SAT is exceeded, or its ability to generate new 
adipocytes is impaired because of genetic predisposition or stress for example, fat 
begins to accumulate in areas outside of the subcutaneous region (Ibrahim 2010). It 
is storage within the visceral region that is thought to pose the greatest risk of 
metabolic disease (Gastaldelli et al. 2002).  
 
VAT and SAT differ with respect to their endocrine function, lipolytic activity, response 
to insulin and other hormones (Ibrahim 2010). Because of its anatomical position, 
visceral fat venous blood is drained via the portal vein directly to the liver as opposed 
to venous drainage associated with SAT. Drainage differences may contribute to the 
strong association between VAT and insulin resistance (Bergman et al. 2006) given 
that portal drainage allows direct hepatic access to FFA and adipokines secreted by 
visceral adipocytes. This direct release into the portal vein may contribute to insulin 
resistance downstream (Figure 2.2). 
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Figure 2.2 - Energy surplus results in accumulation of TAG in adipocytes at 
subcutaneous adipose tissue, which acts as a metabolic sink. When 
capacity of subcutaneous fat is exceeded or if it is impaired, fat will 
accumulate in areas outside the subcutaneous compartment (Adapted 
from Ibrahim et al. 2010) 
 
The inflammatory profile of VAT and SAT differ substantially. The dominant source of 
inflammatory protein release is the visceral adipose depot (Fried et al. 1998; Bruun et 
al. 2005; Bosanska et al. 2010), although it has been previously shown (Gletsu et al. 
2006) that IL-6 was more abundant in the SAT rather that VAT. Additionally 
adiponectin abundance has been shown to be greater within SAT (Fain et al. 2004; 
Lihn et al. 2004). Despite reported higher concentrations of inflammatory proteins in 
VAT, when contextualised SAT may provide a more substantial contribution toward an 
overall state of chronic low-grade inflammation in comparison to VAT because of the 
volume of tissue.  
 
2.6 Chronic low grade inflammation, insulin resistance and T2DM 
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the pro-inflammatory cytokine TNF-α induced insulin resistance. Later additional 
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inflammatory mediators were described as being products of adipose tissue (Zhang et 
al. 1994; Shimomura et al. 1996; Fried et al. 1998; Steppan et al. 2001; Fukuhara et 
al. 2005). Whilst the likes of leptin and adiponectin are true ‘adipokines’ being 
produced exclusively by adipocytes, others such as TNF-α, IL-6, MCP-1 are highly 
expressed in other cells and activated macrophages. The relative inflammatory 
contribution of the aforementioned cell types to inflammatory output is still uncertain. 
 
Primarily insulin resistance is mediated by 2 pathways, JNK and IKKβ / NF-κB with 
each being operationally diverse. JNK has been shown to promote insulin resistance 
through phosphorylation of serine residues in IRS-1, inhibiting the normal tyrosine 
kinase cascade through counter-regulatory serine/theonine phosphorylation (Zick et 
al. 2005). In contrast IKKβ liberates NF-κB for translocation into the cell nucleus where 
it promotes the expression of numerous target genes whose products induce insulin 
resistance (Figure 2.3).  
 
In addition to inflammatory cytokines other stressors such as reactive oxygen species 
(ROS) and endoplasmic reticulum (ER) stress have been shown to activate JNK and 
NF-κB. Markers of oxidative stress increase in line with increases in adiposity which is 
consistent with a role for ROS in the development of obesity induced insulin 
resistance. A potential mechanism for this action has been described and involves the 
activation of NADPH oxidase by lipid accumulation within the adipocyte with a 
complimentary rise in ROS production (Ruperez, Gil and Aguilera 2014).  
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Figure 2.3 - Potential cellular mechanisms for activating inflammatory signalling. Obesity 
activates IKKβ / NF-κB and JNK pathways in adipocytes, hepatocytes and 
associated macrophages. Intracellular stresses such as ROS and ER have also 
been demonstrated as stimuli able to activate these pathways (Adapted from 
Shoelson, Lee and Goldfine 2006).  
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2.7 Exercise training and chronic low-grade inflammation 
A large body of evidence stretching beyond the scope of this current review exists as 
to the effects of exercise training on inflammatory regulation (Gleeson et al. 2011) in 
health and disease (Adamopoulos et al. 2002; Zoppini et al. 2006; Oberbach et al. 
2008; Gray et al. 2009; Balducci et al. 2010; Leggate et al. 2012). The true 
mechanisms contributing to an exercise induced anti-inflammatory environment 
remain un-clear. Mechanisms such as those relating to increased release of cortisol 
and adrenaline; reduced expression of toll like receptors (TLRs) on macrophages; 
inhibition of adipose tissue infiltration by macrophages are amongst many pathways 
all of which are likely to be involved in reducing inflammation (Gleeson et al. 2011). An 
important consideration is how specific exercise modalities and intensities contribute 
to the promotion of these anti-inflammatory mechanisms. High volume continuous 
moderate exercise for example may act via adipose tissue specific pathways whereas 
higher intensity shorter duration exercise is likely to mediate catecholamine modulated 
pathways. The contribution of these independent exercise modalities to inflammation 
related health status within the ‘at-risk’ population remains un-defined. 
 
Most studies investigating the interaction between exercise and inflammatory status 
show commonality in use of low to moderate intensity exercise, often less than 60 % 
V̇O2max with only recently work (Leggate et al. 2012) beginning to look at the potential 
benefit of exercise at higher intensities and differing exercise paradigms. For example, 
work in the healthy population (Gray et al. 2009) has demonstrated that a 12 week 
walking intervention was unsuccessful in inducing changes in plasma c-reactive 
protein (CRP), IL-6, sIL-6R, TNF-α or its receptors, in previously inactive participants 
(< 30 min of moderate exercise 5 x per week). In support, Keller et al (2005a, 2005b) 
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ran a 10 week training study in 7 untrained but otherwise healthy males. Despite 
training for 1 h per day, 5 x per week at 75 % maximal power output no significant 
reductions in inflammation occurred. Clearly sample size must be considered when 
reviewing this work and may explain the non-significant changes. Utilising a larger 
sample size Ho and colleagues (2013) subjected 64 over weight and obese individuals 
to 12 wks of aerobic exercise consisting of 30 min of treadmill running at 60 % HRR, 
5 x per week. Data reveal that after training there were significant reductions in TNF-
α but no change in IL-6.  Correspondingly, Oberbach et al. (2006) found no change in 
IL6, CRP, IL-10 or adiponectin following 4 weeks of moderate intensity exercise in a 
healthy cohort. Of note however was a reduction in inflammatory profile within those 
with prior metabolic abnormalities. 
 
Exercise of a higher intensity was used by Gray and colleagues (2009), who 
conducted training in sedentary, overweight but otherwise healthy males. After 12 and 
24 weeks of progressive moderate intensity training (~ 70 % V̇O2max) IL-6 was 
significantly reduced. Through utilisation of a non-exercise de-training period the 
authors (Gray et al. 2009) reported that IL6 increased, returning close to baseline 
levels; bringing into question the strength of the initial exercise effect. Furthermore 
these data give rise to speculation that exercise intensity may be the critical factor in 
inducing positive changes within the inflammatory profile. Leggate et al (2012) 
demonstrated within an overweight and obese group, that in just 2 weeks plasma sIL-
6R and MCP-1 as well as IL-6 in adipose tissue decreased following HIT based 
training. Training consisted of 10 x 4 min of cycling at 85 % V̇O2max performed 3 x per 
week. Balducci and colleagues (2010) demonstrated that 12 months of training, twice 
per week at 70 %- 80 % V̇O2max reduced inflammation in T2DM patients and in those 
with metabolic syndrome. Levels of IL-6, TNF-α and CRP were all reduced with levels 
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of IL-10 increased. Increased IL-10 in association with increased levels of adiponectin 
after training promotes the current theory that adiponectin induces production of IL-10 
in macrophages and monocytes (Wolf et al. 2004). Given the disparity between results 
in this (Balducci et al. 2010) work and that of previous studies suggests that higher 
exercise intensities are critical in order to reduce TNF-α especially when body mass 
is unchanged as found by Balducci et al. (2010). Associations with adiponectin need 
further attention given the work to suggest the independent inflammatory roles of 
multiple adiponectin isoforms (Lara-Castro et al. 2006). 
 
These data and those mentioned above give rise to the conclusion that exercise 
intensity is a key component in the reduction of inflammation. Evidence suggests that 
exercise training may be a suitable treatment / prevention strategy for the treatment of 
inflammation in the circulation and in adipose tissue. There is emerging evidence to 
suggest that intensity of exercise may be critical in inducing an anti-inflammatory 
response with the possibility of an inflammation-exercise intensity dose response 
relationship although more work is required to confirm or deny this.  
 
Work suggests that resistance training may be an alternative exercise stimulus 
capable of stimulating a beneficial effect on some inflammatory mediators. For 
example 1 year of moderate intensity resistance training, at least twice per week in 
overweight women was shown to induce reductions in CRP and increase adiponectin 
despite no changes detected in IL-6, ICAM-1 and irrespective of there being no 
changes body fat or fat mass (Olson et al. 2007). The comparison of resistance and 
aerobic training was made by Donges et al (2010). Ten weeks of resistance training 
but not aerobic training reduced levels of circulating CRP in an overweight cohort. 
Despite this change, no changes were detected in IL-6 for either group. With support 
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of the above evidence it may be suggested that resistance training offers some 
potential benefits for reduction of some pro-inflammation proteins notably CRP, yet 
may not induce improvements in others such as IL-6, at least within a healthy 
population. Resistance exercise may act as an effective supplement to a mixed 
modality exercise programme.  
 
Further studies have investigated the effects of exercise training in diseased 
populations including those with metabolic diseases such as T2DM and the metabolic 
syndrome; that are partly defined by having elevated levels of chronic low-grade 
inflammation. Twelve weeks of exercise has been shown to be effective in reducing 
IL-6, sIL-6R, and TNF-α in chronic heart failure patients (Adamopoulos et al. 2002) 
with patients having exercised for 30 min, 5 x per week at 60 % - 80 % of maximal 
heart rate. These findings were not completely replicated in a T2DM population who 
undertook 4 weeks of moderate intensity exercise 4 days per week (Oberbach et al. 
2006). T2DM patients and those with impaired glucose tolerance failed to change IL-
6 or IL-10 after training however did show improvements in CRP and increases in 
adiponectin. Moderate intensity exercise induced reduction of inflammatory proteins 
such as intercellular adhesion molecule 1 (ICAM-1) which has been shown on a 
number of occasions in ‘at risk’ populations, specifically the obese, those with impaired 
glucose tolerance and those with T2DM. Short and long term exercise interventions 
have reduced ICAM-1 concentrations in T2DM patients specifically with interventions 
ranging between 3 / 4 weeks - 6 months with frequencies ranging from 1–7 days per 
week (Roberts et al. 2006a, 2006b; Zoppini et al. 2006; Tonjes et al. 2007). 
Interestingly the same exercise interventions were proven unsuccessful in healthy 
participants (Zoppini et al. 2006). Exercise interventions incorporating both aerobic 
and resistance exercise were effective in reducing MCP-1 concentrations in male 
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T2DM patients (Troseid et al. 2004). Interestingly, in the majority of the 
aforementioned investigations changes in MCP-1 or ICAM-1 were associated with 
significant reductions in weight loss. This suggests that adiposity may be the critical 
factor moderating inflammatory profile subsequently rendering it impossible to 
determine the true independent effect of exercise. These data further suggest that 
exercise training may be an effective method of treating inflammation with clinical and 
sub-clinical populations.  
 
From evidence reported here this gives rise to the suggestion that diseased 
populations may benefit from accessing monitored and controlled high intensity 
training which may give rise to more marked changes in inflammatory profile over a 
shorter period of time, however may equally benefit from longer duration exercise 
modalities which target adipose specific inflammatory pathways. 
 
As alluded to, the anti-inflammatory effect of exercise is likely mediated via a collective 
of pathways some of which are specific to adipose tissue. With this in mind weight loss 
or more specifically reductions in adipose tissue plays an important role in the 
reduction of inflammation. Reported weight loss in previous work has been variable 
and primarily attributed to poor dietary control. Interventions that have controlled 
dietary restriction well, alongside exercise for weight loss have demonstrated positive 
improvements. Bruun and colleagues (2006) demonstrated a ~18 kg reduction in body 
mass with accompanying reductions in circulatory IL-6, CRP and MCP-1 following 15 
weeks of both moderate intensity exercise and a hypo-calorific diet in a morbidly obese 
population.  
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Supporting the work of Bruun et al (2006) using a similar protocol, Christiansen et al 
(2010a) found that IL-6 and MCP-1 were significantly reduced with adiponectin 
significantly improving. This 3 month combined diet and exercise intervention induced 
~ 12 kg weight loss with an exercise only group demonstrating a much smaller ~ 3.5 
kg weight loss. This less prominent weight change was accompanied by no change in 
inflammatory proteins or adiponectin. These data give rise to the suggestion that 
targeting inflammatory pathways specifically associated with adipose tissue, using 
exercise and caloric restriction, poses as an effective strategy for the reduction of 
inflammation. It would seem however that weight reduction in the region of ≥ 3-5 kg 
may be required for meaningful inflammation related health benefits. 
Clearly exercise training is able to improve inflammation in both healthy and diseased 
populations. Interventions utilising exercise ≤ 60 % V̇O2max may not be as effective in 
reducing inflammation as exercises set at intensities ≥ 70 % V̇O2max. Additionally, 
reduction in inflammation is partly driven by changes in adiposity; hence exercise 
interventions with accompanying dietary restriction may be the most successful 
method of improving inflammatory profiles. New data investigating HIT exercise 
proves promising, providing a new exercise paradigm that may induce rapid reductions 
in inflammatory profile.  
 
2.8 High intensity interval training and body composition  
Aerobic exercise programmes, typically of low to moderate intensity of 30 min - 40 min 
over 3 or 4 days of the week have been shown to increase cardiorespiratory fitness 
(Ross et al. 2000) and preserve fat free mass (Evans et al. 1999). These training 
programmes have been the most frequently adopted by the general population to 
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improve health, however the resultant overall fat loss has been shown to be minimal 
(Boutcher and Dunn 2009; Wu et al. 2009).  Furthermore given that the estimated 
optimal dose of aerobic exercise required to significantly reduce visceral fat is 3780 
kcal expended per week (Ohkawara et al. 2007) it is likely that the overweight and 
obese populations may find difficulty in adhering to such high weekly workloads.  
 
HIT may offer a novel alternative to aid in the reduction of body fat. In a recent study 
Heydari et al. (2012) subjected 14 men and 13 women to either a 20 week programme 
of endurance training (4 - 5 sessions per week, 30 – 45 min in duration at an intensity 
equating to 60 % - 85 % of maximal HRR) or a 15 week high intensity programme (10 
s - 30 s of high intensity bouts at 60 % – 70 % of maximum work output in 10 s, 
separated by recovery dependant on heart rate recovery). Body composition was 
assessed by using the sum of 6 skin folds, with an average taken from 3 valid 
measurements. Results demonstrated striking differences in total EE between the 2 
training paradigms. Despite no change in body weight pre and post training in either 
endurance (60.6 ± 13.4 kg and 60.1 ± 12.1 kg respectively) or HIT group (63.9 ± 11.0 
kg and 63.8 ± 11.5 kg respectively), the HIT group had a tendency for greater 
reductions (14 %) in the sum of 6 skinfolds. The endurance training group reduced 
sum of 6 skinfolds by 5.7 %. However when looking at the baseline sum of 6 skinfold 
measurements, it would appear that the HIT group had 17 % higher values compared 
to the endurance trained group. This difference is larger than the difference found pre 
and post exercise for skinfolds in the interval training group (14.8 %). Evidence 
suggests that given a higher degree of body fatness, the greater the potential to show 
reductions following training, as described in the correlation presented by Trapp et al 
(2008). Had groups been more accurately matched, then the difference between the 
groups would not be as marked. 
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Trapp et al (2008) compared fat loss between HIT and continuous based exercise as 
well as including a non-exercising control group. Body composition was assessed via 
DEXA scans which were taken before and after the training programme. The HIT 
training consisted of 8 s ‘all out’ bouts of cycling followed by 12 s rest. These reps 
continued for a maximum of 60 efforts, with the authors stating exercise time to be 
between 5 min and 20 min depending on ability. The continuous steady state exercise 
group performed 20 min - 40 min of cycling at an intensity equivalent to 60 % V̇O2peak. 
A control group consisted of non-exercising participants who maintained dietary and 
physical activity diaries as evident within the exercising groups and simply carried out 
pre and post assessments. Data revealed a significant degree of fat loss achieved in 
the HIT group (2.5 ± 0.83 kg) compared to increased fat mass shown in the continuous 
moderate exercise group (0.44 ± 0.88 kg) and control group (0.33 ± 0.47 kg). 
Furthermore, HIT exercise induced a significant reduction in central abdominal fat (-
0.15 ± 0.08 kg). Both continuous and control groups showed increases of 0.1 ± 0.08 
kg and 0.3 ± 0.04 kg respectively. The authors attribute the stronger response from 
HIT to be enhanced lipid utilisation however the precise mechanisms have yet to be 
elucidated. The methods employed by the authors to estimate EE lacked precision 
and therefore it cannot be reliably concluded that energy balance was unaffected in 
the HIT group. Energy expenditure was estimated by converting the workload for each 
session into oxygen consumption in L.min-1. A more accurate methodology may well 
include continuous on-line measurement during exercise. This would provide breath-
by-breath data allowing for estimation models to be applied to accurate O2 and CO2 
data. It may also be feasible that changes in fat mass may have been influenced by 
unreported changes in diet. Additionally the same may be true when rationalising the 
increase in fat mass in both continuous exercise and control groups. The use of 
various ethnicities within the study may also be reason to view this data with caution. 
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It is recognised for example that the South Asian population have a higher percentage 
of body fat at any BMI compared to a Caucasian population (Lear et al. 2007), and 
thus a greater potential for fat loss. There may also be evidence to suggest that the 
metabolism of fat differs between ethnicities (Kuller 2004) and as such using a mixed 
ethnicity cohort may not be the most accurate method of assessing changes in body 
fat. 
 
Possible mechanisms underlying fat loss following HIT based exercise involve 
increased exercise and post-exercise fat oxidation with potentially decreased post-
exercise appetite. Gaitanos et al. (1993) suggest that towards the end of a HIT session 
consisting of multiple repetitions, an inhibition of anaerobic glycogenolysis occurs. 
Moreover it is proposed that ATP resynthesis is mainly derived from PCr degradation 
and intramuscular TAG stores. The increase in blood glycerol has been shown to 
accompany HIT in trained (Trapp, Chrisholm and Boutcher 2007) and un-trained 
(Talanian et al. 2007) cohorts, thus supporting the theory that progressively through 
training, HIT exercise may result in increased fatty acid transport. An increased 
capacity for fat oxidation has been described previously (Burgomaster et al. 2005) 
following as little as 6 session of HIT.  
 
In summary HIT has been shown to be beneficial for fat loss in a limited number of 
studies, however the various limitations within these studies warrant further 
investigations that impose more robust measurement strategies, looking exclusively 
at manageable forms of HIT as the training stimulus and in direct comparison with 
continuous exercise modalities across a diverse range of experimental cohorts.  
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2.9 HIT and excess post exercise oxygen consumption 
One possible mechanism previously proposed (Boucher et al. 2011) for fat loss relates 
to elevations in post-exercise metabolic rate. Excess post exercise oxygen 
consumption (EPOC) has been proposed as a possible mechanism for fat loss 
following exercise (Boutcher 2011). It is particularly pertinent to address the effect of 
HIT upon EPOC which will be explored in detail in chapter 3. 
 
The term EPOC was developed by Gaesser and Brooks (1984) and describes 
elevations in metabolic rate above that of basal levels, over an extended period of time 
following exercise. EPOC can be divided into 2 distinct components, firstly the rapid 
component, which describes the sum of components that decays within approximately 
1 h; and a slow component with a half-life in the order of several hours (Bahr 1992). 
Processes that are active beyond the first hour after exercise must be responsible for 
the slow EPOC component (Borsheim and Bahr 2003).  
 
Brockman et al (1993) investigated HIT in five well-trained females. Females 
completed both 10 min of running at 80 % V̇O2max as well as a HIT protocol, which 
incorporated 7 x 2 min of sprinting at an intensity of 90 % V̇O2max, with 2 min of active 
recovery between bouts (~ 5 km.h-1), noting an increased EPOC of 3.31 L. The same 
group also completed a 2 h walk at 25 % V̇O2max which produced only a small EPOC 
of 1.52 L suggesting that HIT based training may be more successful than continuous 
exercise in elevating mechanisms associated with increased metabolic rate after 
training.  
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A key study comparing continuous versus interval exercise came from the work of 
LaForgia et al (1997). Data indicated that the intermittent bout resulted in an EPOC of 
15.0 L (measured over 9 h after exercise) which was 2.5 times higher than the EPOC 
achieved following the energy matched continuous exercise bout (6.9 L). The duration 
of EPOC also varied significantly, with the EPOC attributed to intermittent exercise 
lasting 9 h before returning to baseline values. This was in contrast to an EPOC lasting 
only 2 h following the continuous protocol. Interestingly, when comparing these data 
to that reported within the Gore and Withers (1990a, 1990b) it is clear that their 
reported EPOC following 80 min of continuous exercise at 70 % V̇O2max (14.6 L) is 
similar to that achieved following intermittent exercise in LaForgia (1997), despite the 
continuous exercise involving twice the amount of total work done. Furthermore 
relating to the LaForgia study, EPOC measurements were not taken during the 
recovery periods during the intermittent protocol. Despite not measuring this 
parameter the authors did address this limitation and estimated that the total EPOC 
from these rest periods would probably amount to an additional oxygen consumption 
of 2-3 L.  
 
In conclusion these data further demonstrate the importance of exercise intensity for 
significant elevations in post-exercise metabolic rate. Of equal importance is the 
suggestion that greater elevations in EPOC are demonstrated following the 
intermittent exercise modality over classical continuous forms of exercise, regardless 
of intensity.  
 
Further work matching total sub-maximal work done in both continuous and 
intermittent exercise has been conducted. McGarvey, Jones, Peterson (2005) aimed 
to identify if O2 consumption was different over a 2 h post-exercise period following 
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continuous and HIT based exercise. The findings from this study indicated a higher 
total O2 consumption and RER during exercise in the intermittent protocol compared 
to the continuous protocol. Although precise values were not reported, the authors 
quote that EPOC duration was on average 4 min longer for the intermittent exercise 
condition compared to continuous. Despite significant differences being found during 
exercise, there was no significant difference between the magnitudes of EPOC 
following intermittent or continuous exercise. This work is limited given that baseline 
resting metabolic rate (RMR) values were collected 20 min prior to exercise. This 
would potentially provide elevated V̇O2 levels due to the anticipatory response of the 
subject. Furthermore, through the work of MacDonald et al (1998) it is appreciated that 
in the supine position V̇O2 kinetics are slowed to a rate lower than that of a participant 
sat in an upright position. 
 
Continuing with the work of McGarvey et al (2005), the physiological responses to their 
2 exercise modalities varied, with RER values being lower in intermittent exercise 
compared to continuous, for nearly the whole 2 h recovery period. Although the initial 
dip in RER within the 30 min - 40 min of recovery (for both modalities) may be 
attributed to CO2 retention and lactate buffering, the continued low RER into the 
second hour for the intermittent exercise would seem to be reflective of a greater 
reliance of fat metabolism. This is in agreement with the work of Yoshioka et al (2001) 
who investigated how HIT based exercise acutely altered EE and lipid utilisation. 
Participants were assigned to complete rest, continuous moderate or HIT based 
exercise. The group failed to give the full details of the protocols employed however 
utilised intensities of 35 % and 77 % V̇O2max for the moderate and intermittent exercise 
respectively. They further note that fat oxidation tended to be greater following the high 
intensity condition compared to moderate.  
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Warren et al (2009) made the point that EE would have to remain significantly elevated 
for several hours post exercise in order to have a beneficial effect on fat loss. Knab 
and colleagues (2011) investigated the effects of ~ 45 min of continuous cycling on 24 
h EE (during exercise and at rest) using a whole room calorimeter system. Specifically 
this group used a protocol consisting of 2 min at 50 %, 2 min at 75 % and 41 min at 
50 % and a further 2 min at 50 % of ‘maximum work load’ (57 % maximum work load 
= 70 % V̇O2max). The exercise protocol itself resulted in a net EE of 519 ± 60.9 kcal. Of 
greater importance EE remained significantly elevated for 14.2 h following exercise, 
corresponding to an additional 190 ± 71.4 kcal. These data suggest that HIT exercise 
may have a significant effect upon post-exercise metabolism.  
 
Recently Larsen and colleagues (2013) investigated the impact of metabolic syndrome 
on EPOC response to high intensity exercise. Seven metabolic syndrome patients 
completed 1 x 4 min cycling at 85 % - 95 % HRmax, 4 x 4 min cycling at the same 
intensity, separated by 3 min recovery periods vs. 47 min continuous cycling at 70 % 
HRmax all separated by at least 48 h. Data demonstrated that EPOC length did not 
differ significantly between HIT and continuous exercise trials. These data should be 
viewed with caution given the short baseline RMR measurement period. Additionally 
oxygen samples were collected as 1 min averages which may mask some variability 
within the V̇O2 kinetics, subsequently effecting AUC calculations. These data were 
replicated by Williams et al (2013) who demonstrated no significant differences in 
EPOC following 4 x 30 s all out SIT sprints, 60 min continuous moderate cycling at 60 
% V̇O2peak or a resting control as measured over a 3 h period. 
 
In summary, exercise has been shown to increase metabolic rate above that of 
baseline. There is to date no clear evidence that HIT exercise is more effective than 
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traditional endurance exercise in elevating EPOC over an extended period of time. 
There is a clear need for more commonly utilised HIT protocols to be profiled with 
regard their contribution to EPOC. It is the aim of the next chapter to explore further 
the effects of HIT on EPOC and to ascertain a detailed profile of HITs benefit for fat 
loss. It is the aim of the next chapter to explore further the effects of HIT on EPOC and 
to ascertain a detailed profile of HITs potential benefit for fat loss. 
 
Aims of thesis: 
 
 To profile the EPOC associated with HIT and AIT training and to draw 
conclusions upon this mechanisms contribution to fat loss. 
 
 To establish the minimum HIT training volume required in order to improve 
markers of cardio-metabolic health.  
 
 To determine if short and medium term HIT training can improve glucose control 
in an obese population 
 
 To determine if short and medium term HIT training can reduce the 
inflammatory profile in overweight and obese individuals.   
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3CHAPTER 3 
 
 
 
GENERAL MATERIALS AND METHODS 
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3.1 Participants and ethical approval 
All studies presented in this thesis were approved by the Loughborough University 
Ethical Advisory Committee and were conducted in accordance with the Declaration 
of Helsinki (2008). The volunteers gave informed written and verbal consent after 
being advised of all possible risks and discomforts associated with the procedures 
used in the study designs. 
 
All participants were asked to complete a health-screening questionnaire at the time 
of consent to ascertain suitability for the study. Any participants reporting 
haematological or inflammatory disorders, or were taking any non-steroidal anti-
inflammatory drugs (NSAIDs) were excluded from taking part. 
 
All participants with a BMI > 30 kg.m2 were subjected to a physical exam including 
resting ECG and full cardiopulmonary stress test to ensure a normal cardiovascular 
response to incremental exercise. Any participants presenting with arrhythmia at rest 
or during the exercise test were excluded from the research and referred for further 
clinical investigation at cardiology outpatients (Leicester Glenfield Hospital). 
 
3.2 Anthropometric measurements 
Participant’s height and body mass were measured prior to all experimental tests. 
Height and body mass were determined using a balanced beam scale with attached 
stadiometer, with participants wearing shorts, t-shirt and no footwear. Waist and hip 
circumferences were measured with a measuring tape. Waist circumference was 
measured half way between the iliac crest and the lowest rib. Hip circumference was 
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measured at the widest part of the hips. These measurements were used to calculate 
mean waist-hip ratio. 
 
Total body composition was measured by dual-energy X-ray absorptiometry (DEXA) 
using a Lunar Prodigy (GE corporation, Fairfield, Connecticut, USA). The output 
segmented 3 compartments of fat mass, bone mineral content and fat free soft tissue, 
the last 2 of which constitute fat-free mass and percentage body fat. DEXA has been 
validated as a measure of body fat in obese and normal weight individuals (Paradisi 
et al. 1999; Van, Mayclin 1999; Bertin et al. 2000).  
 
3.3 High intensity intermittent training 
A HIT protocol utilised in chapters 4 and 5 consisted of 10 x 1 min intervals at a load 
equivalent to ~ 90 % HRpeak separated by 1 min recovery performed on a cycle 
ergometer (Little et al. 2011). Participants completed a familiarisation trial for the HIT 
protocol before all main trials. During this visit participants completed 5 x 1 min 
intervals followed by 1 min recovery. This session allowed the external work to be 
calculated for the HIT trial.  
 
3.4 Glucose tolerance testing 
Participants attended the laboratory having fasted for at least 12 h overnight. Plasma 
insulin and glucose were determined from venous blood samples collected into EDTA 
monovettes from a 21 GA cannula inserted into an antecubital vein. Blood samples 
were collected before and 30 min, 60 min, 90 min and 120 min after ingestion of 82.5 
g dextrose monohydrate dissolved in 200 ml of water. This solution was immediately 
followed by 100 ml of water. Blood samples were immediately centrifuged at 1600 x g 
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(10 min at 4o C) and the plasma aliquoted into labelled Eppendorf tubes and stored at 
-80 oC until the analysis of glucose and insulin. Insulin sensitivity was determined by 
the insulin sensitivity index (ISI) calculated using the oral glucose tolerance test 
(OGTT) glucose and insulin values from the formula proposed by Matsuda and 
DeFronzo (1999). The AUC for plasma insulin and glucose were calculated from 
before to 120 min after ingestion of the dextrose drink using the trapezoidal method. 
 
3.5 Blood pressure 
In chapters 5 and 6 arterial blood pressure was measured using a digital automatic 
blood pressure monitor (Omron M7. Omron Healthcare UK Ltd, Milton Keynes, UK). 
Participants remained in a seated position for 5 min before the 1st measurement. A 
cuff was placed around the upper dominant arm, which rested on a firm surface at the 
level of the heart during all measurements. Blood pressure was measured 3 times with 
results reported as an average of the 2nd and 3rd readings. 
 
3.6 Blood sampling and handling 
Repeated blood samples were collected from a 21 GA BD Venflon cannula (Becton 
Dickinson Infusion Therapy, Helsingborg, Sweden) via an antecubital vein. The 
cannula was kept patent via regular flushing with 0.9 % (w/v) saline solution. The first 
2 ml of blood extracted from the cannula via a syringe was discarded. Blood samples 
were collected into BD vacutainers (BD, Plymouth, UK) containing either 1.8 mg EDTA 
per ml of blood (glucose and inflammatory hormones) or 17 IU lithium heparin per ml 
of blood (insulin). Blood samples were gently inverted 8 times and then placed on an 
SRT6 Stuart roller mixer (Bibby Scientific Ltd, Stone, UK) to ensure mixing. Whole 
blood glucose was analysed immediately via a glucose oxidase reaction, using an 
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automated analyser (YSI Stat 2300, Yellow Spring Instruments, Yellow Spring OH, 
USA). Remaining samples were centrifuged at 1600 x g for 10 min at 4 ºC (Heraeus 
Labofuge 400 R, Kendro Laboratory Products, Langenselbold, Germany). The 
resulting plasma was aliquoted into Eppendorf tubes and stored at  
- 80 ºC for subsequent analysis. Participants were in a seated position throughout all 
sampling periods with the arm continuously air warmed in order to collect arterialised 
venous samples.  
 
3.7      Dietary Controls 
Prior to entry to the lab, participants were asked to record their dietary intake over a 
24 h period as accurately as possible. Participants were familiarised with electronic 
weighing scales and were advised on how to record food weights and times of 
consumption. Prior to all subsequent visits, participants were asked to replicate this 
diet as accurately as possible, so to ensuring consistency across trial periods. 
Additionally participants were asked to restrain from alcoholic or caffeinated drinks in 
the 24 h prior to trial but were free to consume water ad libitum, this information also 
being recorded. 
 
Within chapter 6, participants were advised not to change their diets during a 6 wk 
training period. In order to monitor this, participants completed 4 day diet diaries on 2 
separate occasions (separated by at least 1 week) prior to trial commencement. As 
above, participants were fully familiarised with electronic food scales and advised on 
how to accurately complete the 4 day diary. This provided an average baseline for 
dietary intake. Participants completed the 4 day diet diary again during week 3 of 
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training in order to ensure maintenance of the pre-trial food intake. For detail please 
review methodology within the chapter. 
  
3.8 Enzyme linked immunosorbent assays 
Insulin, adiponectin and MCP-1 were quantified using commercial sandwich enzyme 
linked immunosorbent assays (ELISAs). Both TNF-α and IL-10 were measured via 
high sensitivity assays (R & D systems, Minneapolis, MN, USA). 
 
Plasma IL-6, sIL-6R, and CRP were analysed via ‘in-house’ ELISAs. All materials and 
chemical reagents were obtained from Sigma-Aldrich Ltd (Poole, UK) unless otherwise 
specified. All incubation periods were at room temperature and during each incubation 
stage the plate was placed on a Stuart Mini Orbital Shaker (Bibby Scientifc Ltd, Stone, 
UK) at 60 revs.min-1 unless otherwise stated. Wash steps for ELISAs were carried out 
manually using a multi-channel pipette (Sartorius, NY, USA). The absorbance of wells 
was read using a Varioskan Flash Mutimode Reader (Thermo Scientific, Vantaa, 
Finland). Protein concentration of samples was determined in relation to a 4-parameter 
logistic standard curve.  
The equation of the curve is given below: 
 
X = log EC50 – LOG10((Top – y ) / (y – Bottom))*(1/Hillslope) 
 
Where X is the sample concentration; y is the absorbance; EC50 is the middle of the 
curve. All samples were analysed in duplicate and were repeated if the coefficient of 
variation (CV) between duplicates was more than 10 %.  
 
 57 
 
3.9 Interleukin 6 assay  
An ELISA for the detection of plasma IL-6 was optimised using a human IL-6 antibody 
set (OptEIA, BD Biosciences, Oxford, UK) containing a primary and secondary 
antibody and recombinant human IL-6 (rhIL-6) for standards. Immulon 4HBX Flat 96-
well microtiter plates (Nunc, Thermo Scientific, Roskilde, Denmark) were coated with 
100 µl anti-human IL-6 monoclonal capture antibody diluted 1:250 in a 0.1 M sodium 
carbonate buffer. The next day the plates were washed with Tris Buffered Saline 
(TBS), pH 7.5 with 0.05 % Tween 20 (TBS-T) 3 times, and then blocked with 5 % 
bovine albumin serum (BSA; Probumin, Millipore, Illinois, USA) in TBS. The plates 
were incubated for 1 h at room temperature. Afterwards, plates were washed and 100 
µl of samples and standards were added to the wells in duplicate. Plasma samples 
were diluted 1:5 in TBS with 10 % foetal calf serum (FCS). The rhIL-6 was serially 
diluted in TBS with 10 % FCS from 20 to 0.156  
pg.ml-1. TBS with 10 % FCS served as the zero standard. After 2 h plates were washed 
6 times and the 100 µl of biotinylated anti-human IL-6 monoclonal antibody detection 
antibody diluted 1:250 in TBS-T with 1 % BSA was added per well. Plates were further 
incubated for 1h before being washed 7 times. The enzyme streptavidin alkaline 
phosphatase (AKP) was diluted 1:2000 in TBS with 1 % BSA and 100 µl added per 
well. Plates were then incubated for 45 min. Washes were repeated as in the previous 
step before the addition of an ELISA amplification system (Invitrogen, Paisley, UK). In 
the first step 50 µl of substrate solution was added to all wells and plates incubated on 
the bench top before adding 50 µl of the amplification solution. The reaction was 
stopped within 15 min of the amplification solution being added by the addition of 10 
% hydrochloric acid (stop solution) and the absorbance read at 490 nm with a 
correction wavelength of 690 nm. This assay measured total IL-6 content. 
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3.10 Soluble interleukin 6 receptor assay 
Plasma sIL-6R concentration was determined by ELISA via a method adapted from 
Gray et al. (2008). Antibody pairs M5 (capture) and M182 (detection) were used to 
detect sIL-6R. Immulon 4HBX Flat 96-well microtiter plates were coated with 100 µl 
Purified Mouse Anti-Human CD126 capture antibody (Clone M5, BD Biosciences, San 
Diego, USA), diluted in 0.1 M sodium carbonate buffer to give a concentration of 2 
µg.ml-1 and were stored at 4 °C overnight. The next day plates were washed 3 times 
with phosphate buffered saline (PBS) with 0.05 % Tween 20 (PBS-T) and wells 
subsequently blocked with PBS with 10 % FCS (assay diluent). Plates were incubated 
for 1 h before being washed again and adding 100 µl standards or samples to wells. 
Samples were diluted 1:200 in assay diluent. The rhIL-6R (R&D systems, Minneapolis, 
MN, USA) was serially diluted in assay diluent to give standards ranging from 500 to 
0.5 pg.ml-1, was added to each well. Plates were incubated for a further hour before 
washing 5 times. The enzyme Streptavidin Horse Radish Peroxidase (HRP) (BD 
Biosciences) was diluted 1:4000 in assay diluent and 100 µl added per well. 
Meanwhile a substrate solution was prepared. After 45 min the plate was washed 7 
times and 100 µl of the working substrate solution added for 30 min before the addition 
of 50 µl of stop solution. The final absorbance was read at 450 nm with a correction 
wavelength of 570 nm. 
 
3.11 C-reactive protein assay 
CRP was quantified from an ELISA method adapted from (Pawluczyk et al. 2011). 
Immulon 4HBX Flat 96-well microtiter plates were coated with 100 µl of primary anti-
CRP rabbit polyclonal antibody (Abcam, Cambridge, UK), diluted to a working 
concentration of 3.5 µg.ml-1 in 0.05 M sodium carbonate, pH 9.6. The plates were 
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incubated at 4 °C overnight. The following morning the plates were washed 4 times 
with PBS-T and the wells blocked with 100 µl PBS with 1 % BSA (Probumin, Millipore. 
Illinois, USA). The plates were then incubated for 1h at room temperature and then 
washed as before. Afterwards, 50 µl of plasma samples (diluted 1:100 in PBS) or 
standards were added to the wells in duplicate. Human CRP (NIBSC, Potters Bar, UK) 
was used as a calibrant for this ELISA method. A CRP stock of 50 µg.ml-1 was serially 
diluted in PBS to give a standard curve ranging from 1000 to 1 ng.ml-1. The plate was 
incubated at 4°C overnight. On the 3rd day the plates were washed as before and 50 
µl of a secondary mouse monoclonal antibody to CRP (Abcam, Cambridge, UK) 
diluted to a working concentration of 2.7 µg.ml-1in PBS was added to each well. Plates 
were then incubated for 2 h and the wash step was repeated. For the next step, 
polyclonal rabbit anti-mouse IgG conjugated to HRP (Dakeo, Ely, UK) was diluted 
1:1000 in PBS and 50 µl of the diluted solution was added to the wells and plates were 
incubated for 1 h. A soluble substrate solution for the detection of peroxidase activity 
was prepared using SIGMAFAST OPD tablets shortly before the next wash step. One 
o-Phenylenediamine dihydrochloride (OPD) tablet and one urea hydrogen peroxide 
tablet were dissolved in 20 ml deionised water to give a final concentration of 0.4 
mg.ml-1 OPD, 0.4 mg.ml-1 urea hydrogen peroxide, and 0.05 M phosphate-citrate, pH 
5.0. The plates were washed a further 4 times and 50 µl of the substrate solution was 
immediately added to all wells and the colour was left to develop for 5 min before 
stopping the reaction with 100 µl of 10 % hydrochloric acid. The absorbance of the 
wells was read at 490 nm with a correction wavelength at 650 nm. 
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3.12 Insulin sensitivity index 
Insulin sensitivity was estimated using the Matsuda index of insulin sensitivity 
(Matsuda, DeFronzo 1999) which is validated as being an accurate measure, 
correlating highly (r = 0.73) with the rate of whole body glucose disposal during the 
euglycaemic insulin clamp. Insulin sensitivity was calculated using the following 
equation: 
Insulin Sensitivity = 
10,000
√(𝐹𝑃𝐺∗𝐹𝑃𝐼)∗(𝐺∗𝐼)
 
Where FPG is the fasting plasma glucose; FPI is the fasting plasma insulin; G is the 
mean plasma glucose during the OGTT and I is the mean plasma insulin. 
 
3.13 Statistical analysis 
All statistical analysis was performed using SPSS 21.0 software (Statistical Package 
for the Social Sciences Inc., Chicago, Illinois, USA). Data is presented as mean and 
standard deviation (± SD) unless specified otherwise. All data was checked for 
normality using the Shapiro-Wilk test before the main analysis. If data was not normally 
distributed the data was transformed and checked for normality again. The 
transformed, normally distributed data was then used for any subsequent statistical 
analysis to comply with the assumptions of parametric models of analysis.  
 
Data was analysed using a within group, repeated measures analysis of variance 
(ANOVA) model where there were more than 2 comparisons. Post-hoc pair-wise 
comparisons were performed where appropriate according to the Bonferroni 
adjustment method. Paired sample t-tests were used to analyse within group 
differences when there were only 2 comparisons. Delta (Δ) changes between 
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independent groups were analysed via independent samples t-tests. Statistical 
significance was accepted at p ≤ 0.05.   
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4CHAPTER 4 
 
 
 
THE IMPACT OF HIGH INTENSITY INTERMITTENT 
EXERCISE ON RESTING METABOLIC RATE IN 
HEALTHY MALES 
 
1This chapter was accepted for publication (2013) 
  
                                            
1 Kelly B, King JA, Goerlach J, and Nimmo MA (2013). The impact of high-intensity 
intermittent exercise on resting metabolic rate in healthy males. Eur J Appl Physiol 113: 
3039-3047. 
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4.1 Abstract 
High intensity intermittent training (HIT) may favourably alter body composition, 
potentially mechanistically driven by post exercise oxygen consumption (EPOC). This 
chapter assessed the impact of 2 common aerobic interval training (AIT) and HIT 
protocols on energy expenditure (EE) and 11 h EPOC. Oxygen consumption (L·min-
1), respiratory exchange ratio (RER) and EE were measured in 9 healthy, lean males 
(Age:18.5-29.9 years; BMI: 20.3 - 25.0 kg.m-2) over 12 h under three conditions: control 
(CON), HIT1 (10 x 1min high intensity cycling bouts followed by 1min rest) and HIT2 
(10 x 4min high intensity cycling bouts followed by 2 min rest). Total exercise period 
EE during HIT1 (1151 ± 205 kJ) (mean ± SD) was significantly lower than HIT2 (2788 
± 322 kJ; p < 0.001). EE within the 60 min after exercise was significantly higher after 
HIT1 (388 ± 44 kJ; p = 0.02) and HIT2 (389 ± 39 kJ; p = 0.01) compared with CON 
(329 ± 39 kJ), with no difference between exercise conditions. RER during this period 
was significantly lower in HIT1 (0.78 ± 0.06; p = 0.011) and HIT2 (0.76 ± 0.04; p = 
0.004) compared with CON (0.87 ± 0.06). During the ‘slow phase’ of EPOC (1.25 h – 
9.75 h) there were no significant differences in EE or RER between trials. Single 
sessions of HIT induce a transient increase in resting metabolic rate however the 
subtleness of this effect suggests that altered metabolic rate may not contribute 
significantly to previously documented changes in body composition with HIT.  
 
 
 
 
 
 
 64 
 
4.2 Introduction 
Despite the common acceptance that regular physical activity reduces the risk of many 
chronic conditions such as obesity, type 2 diabetes and cardiovascular disease, 
participation in physical activity remains low (WHO 2010). Specifically, within the UK 
approximately two-thirds of men and women do not perform sufficient activity to benefit 
their health (WHO 2010). Traditionally, health oriented physical activity guidelines 
have centred on individuals undertaking moderate intensity aerobic, continuous forms 
of exercise on most days of the week (Department of Health 2011). Given that the 
most commonly cited reason for not participating in physical activity is lack of time, 
and the recent evidence that individuals preferred an intermittent exercise protocol in 
comparison to continuous exercise (Bartlett et al. 2011), it is now timely to consider 
other forms of exercise which can potentially be more readily adopted. 
 
In recent years there has been a surge in interest concerning HIT due to its ability to 
confer notable cardio-metabolic health benefits rapidly, with great time efficiency 
(Gibala & Little 2010). Specifically, HIT has been shown to improve insulin sensitivity 
and glycaemic control (Burgomaster et al 2006, 2008; Gibala et al. 2006; Wisloff et al. 
2007; Tjonna et al. 2008; Babraj et al. 2009; Haram et al.  2009; Nybo et al. 2010; 
Richards et al. 2010; Whyte et al. 2010; Gaesser and Angadi 2011; Hood et al. 2011; 
Little et al. 2011; Shepherd et al. 2013) as well as other cardiovascular health factors 
(Fletcher et al. 1996) in as little as 2 weeks of training (typically six training sessions).  
 
A body of research has also emerged documenting beneficial changes in body 
composition and/or mass in response to HIT (Boutcher 2011) with studies reporting 
favourable changes within short time frames. Accordingly, Whyte et al (2010) 
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subjected overweight and obese males to six training sessions over two weeks with 
each session consisting of four to six 30 s cycle sprints, interspersed with 4.5 min of 
recovery. Along with positive changes in several metabolic health parameters, this 
group noted a significant 2.4 cm reduction in waist circumference. Leggate and 
colleagues (2012) also observed a significant reduction in waist circumference (1.4 
cm) in a group of overweight and obese males following the completion of two weeks 
of aerobic interval training (AIT). In this study each training session consisted of 10 x 
4 min bouts of cycling at ~ 85 % V̇O2peak, separated by 2 min of recovery. Additionally, 
research has hinted that interval training may be superior to continuous moderate-
intensity exercise training for the purpose of adiposity reduction (Macpherson et al. 
2011). In this study 6 weeks of treadmill based SIT induced a two-fold greater 
reduction in total adiposity (12.4 % vs. 5.8 %) compared with a much greater volume 
of continuous moderate-intensity running. Given the relatively short duration of these 
interventions and accumulated exercise volume, the energy expended during exercise 
was unlikely to have been sufficient to account for the reported changes in waist 
circumference/adiposity. However, definitive information regarding this aspect of 
HIT/AIT is lacking and consequently the total impact of low volume interval training on 
energy balance is unknown. 
 
Recently, Knab et al (2011) reported that metabolic rate is augmented for 14 h after a 
single bout of moderate-high intensity aerobic exercise, equating to an additional 795 
kJ EE on top of that expended during exertion. The authors of this previous paper 
suggest that this elevated oxygen consumption may significantly contribute to fat loss 
over the course of exercise training programmes. Although research has been 
conducted to profile excess post exercise oxygen consumption (EPOC) after 
continuous forms of exercise (Borsheim and Bahr 2003; LaForgia et al. 2006), less 
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attention has been given to high intensity forms of exercise (McGarvey et al. 2005; 
Malatesta et al. 2008). Specifically, how high intensity intermittent exercise (HIIE – in 
this chapter representing one single bout of AIT or HIT) impacts upon EE and substrate 
utilisation, both during and after exercise, is not well understood. Given recent reports 
demonstrating notable changes in body composition and/or mass with HIT (Boutcher 
2011) it is necessary to understand how HIT influences these parameters. Recent 
reports have provided preliminary information on this issue (Williams 2013; Chan & 
Burns 2013; Hazell et al. 2012) however in these studies the focus has been on SIT 
based exercise. This type of training may not be feasible for many who are inactive or 
who have chronic conditions e.g. type 2 diabetes or cardiovascular disease. More 
manageable forms of HIT have emerged which are more suitable for such individuals; 
however there is currently no information regarding the impact of these protocols on 
EE and substrate utilisation, during or after exercise. 
 
The present investigation sought to accurately characterise the EE during exercise 
and EPOC (11 h post-exercise) of two commonly used HIT protocols which have been 
developed to be implemented with untrained individuals and/or clinical groups. The 
first protocol (HIT1) examined a HIT intervention which has been demonstrated as 
being suitable for individuals with type 2 diabetes, conferring rapid and marked gluco-
regulatory benefits (Little et al. 2011). The second protocol (HIT2) examined was that 
previously implemented by Leggate et al (2012), where a significant decrease in the 
waist circumference of overweight/obese men was observed after just six AIT training 
sessions. The present investigation aimed to characterise the EE elicited by an acute 
bout of HIT type training in terms of both the immediate and delayed effect. In doing 
so, determining the potential contribution of HIT induced EE to previously documented 
reductions in body fat and/or waist circumference. 
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4.3 Materials and methods 
4.3.1 Participant characteristics 
Nine untrained and moderately active men (defined as doing no more than 2 x ≤ 30 
min of moderate intensity exercise sessions per week with no involvement in any 
structured training for ≥ 2 years) volunteered to take part in the current study. The 
study inclusion criteria demanded that participants had a BMI 18.5-29.9 kg.m-2, and 
had been weight stable for at least three months prior to the study. Participants were 
free of cardiovascular, metabolic and haematological disease and were not taking any 
medications or supplements. The participants were fully informed of the aims, risks 
and discomforts associated with the investigation before providing written informed 
consent. This study conformed to local guidelines, the declaration of Helsinki, and was 
approved by the local ethics committee.  
 
4.3.2 Preliminary measurements 
Before main trials resting metabolic rate (RMR) was measured on two separate 
occasions in order to obtain reliable baseline results (Compher et al. 2006; Roffey et 
al. 2006). For these tests participants reported to the laboratory in the morning (~ 
07:30) having not eaten since the previous evening. Resting metabolic rate 
assessments followed the guidance of Compher et al (2006). In brief, participants were 
asked: not to exercise during the preceding 24 h; not to consume caffeine, alcohol or 
drugs during the preceding 24 h; to remain fasted for at least 10 h prior to laboratory 
entry; to record what they had eaten in the preceding 24 h in order to replicate this 
feeding pattern prior to the second RMR measurement; to eliminate uncontrolled 
activity by travelling to the laboratory by motorised transport, with any essential 
walking being kept to < 50 m. The laboratory temperature was maintained at 23.5 - 
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24.5 °C. To minimise movement participants were assisted when necessary by 
wheelchair.  
 
All resting metabolic measurements were performed using an open circuit, ventilated 
hood indirect calorimetry system (GEM Nutrition Ltd., Cheshire, England). This 
technique has been validated in the measurement of RMR in both adults and children 
(Weissman et al. 1990; Tissot et al. 1995). After a 30 min seated resting period, 
participants were instructed to lie in a comfortable supine position. The clear hood 
canopy was placed over the head area and plastic sheeting attached to the hood was 
placed around the body to form a seal between the air inside and outside the hood. 
Participants were instructed not to talk or fidget and listened to the radio throughout 
the measurement to reduce boredom and to prevent sleeping. V̇O2 (L.min-1), V̇CO2 
(L.min-1), RER and EE (kJ) were determined at 30 s intervals (as pre-determined by 
software) over a 30 min period. For analysis, the first 10 min of data were discarded 
to account for any initial short-term respiratory artefact. Minute averages for V̇O2 along 
with RER caloric equivalents were used to estimate EE. The mean percentage 
difference between the two baseline measurements was 1.6 %. 
 
Before main trials participants also performed a V̇O2peak test to volitional exhaustion 
using an electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, The 
Netherlands). V̇O2 was measured continuously throughout the test using an online 
breath-by-breath gas analysis system (Cortex Metalyzer, CPX International Inc, Berlin, 
Germany). For this test participants first warmed up for 3 min against a resistance of 
50 W. After this, the workload was increased to a starting work rate which was 
subsequently increased by 30 W at intervals of 3 min. The initial work load for the test 
was individualised for each participant, being selected so that the test would last for 
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approximately 12 min (4 stages). The test was terminated when participants could no 
longer maintain pedal cadence at 50 RPM. Data points were collected as 5 s averages 
with V̇O2peak identified over the highest 30 s period during the test. HR was measured 
during the test using a telemetric heart rate monitor (Polar RS100, Polar Electro, UK 
Ltd., Warwick, UK). 
 
4.3.3 Experimental protocol 
All participants completed two HIIE main trials and one control trial with each study 
visit being separated by at least four days. Figure 4.1 provides a schematic overview 
of the main trial protocols. Prior to each main trial participants abstained from 
structured physical activity and standardised their dietary intake within the prior 24 h. 
On the morning of trials participants arrived at the laboratory via motorised transport 
to eliminate extraneous activity. An 11 h EPOC assessment was made across each 
main trial and for clarity and comparability across trials the beginning of this 
measurement point was defined as time zero (0 h). Thus, exercise protocols ended at 
the same time (prior to the start of EPOC assessment) which meant that it was 
necessary for the HIIE start times to differ. Consequently, the beginning of the control 
trial and HIT2 is defined at -67 min which reflects the 60 min exercise period (in HIT2) 
before EPOC measurement, 2 min cool down, and an additional 5 min resting period 
necessary to allow CO2 levels to return to values which fall within acceptable limits for 
transfer to the ventilated hood (essential for the exercise trials). Accordingly, the 
beginning of HIT1 is defined as -27 min which reflects the duration of the 20 min 
exercise protocol as well as the aforementioned 7 min recovery period after exercise 
(Figure 4.1).  
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Figure 4.1 - Schematic representation of testing schedule 
 
For the control trial participants reported to the laboratory in a fasted state at ~ 07:30. 
Participants then relaxed in a comfortable seated position for 30 min prior to the start 
of the trial (- 67 min). At this point breath collection via online gas analysis (Cortex 
Metalyzer, CPX International Inc, Berlin, Germany) began whilst participants remained 
in a seated position. Gas collection occurred continuously for 67 min. This period prior 
to post-exercise assessment is defined as the ‘exercise period’ (EP). Immediately after 
the EP, the rapid phase (RP) of EPOC was measured continuously over 60 min using 
the ventilated hood (0 h – 1 h). During this time, measurements were taken 
continuously with participants resting in a supine position. Immediately after the RP, 
participants were seated next to the ventilated hood where breakfast was provided (1 
h – 1.15 h). Participants consumed breakfast within 15 min, after which point ventilated 
hood measurement recommenced. Subsequently, expired gas analysis was 
performed continuously for 15 of every 30 min over the next 9.75 h. This period was 
identified as the EPOC slow phase (SP). Standardised meals were also consumed by 
participants at 4 h and 8 h with each meal being consumed within 15 min.  
 
Identical procedures were completed in the exercise trials except a bout of HIIE was 
completed at the beginning of trials. During exercise, gas analysis data was collected 
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continuously with V̇O2, V̇CO2, RER and HR averaged every 15 s. Within each protocol 
the 2 min cool down period was composed of cycling against no resistance. The 
exercise protocol within HIT1 was identical to that described by Little et al (2011) (See 
general methods). The exercise protocol within HIT2 was identical to that described 
previously by Leggate et al (2012), consisting of 10 x 4 min intervals at an RPM of 60 
- 80, each separated by 2 min of light pedalling against a set resistance of 50 W. The 
workload was manipulated during the trial to ensure that the average corresponding 
V̇O2 during high intensity bouts equated to ~ 85 % V̇O2peak.  
 
4.3.4 Meals for experimental trials 
During main trials participants were provided with 3 standardised meals which were 
identical across trials. All meals were consumed within 15 min. The total amount of 
energy provided for participants at each meal was individualised to meet daily energy 
requirements for an inactive day. This value was calculated by multiplying each 
individuals average RMR (from preliminary assessments) by 1.375 (Harris et al. 1918). 
Breakfast was provided immediately after the EP (at 1 h) and consisted of toasted 
white bread and jam (30 % of daily energy requirements). Lunch and dinner were 
provided at 4 h and 8 h with both meals consisting of a tuna mayonnaise sandwich, 
salted crisps, chocolate muffin and green apple (each meal 35 % of daily energy 
requirements). The macronutrient composition of the food provided across each trial 
was typical of a UK diet and consisted of 38 % fat, 14 % protein and 48 % carbohydrate 
(Department for Education, Food and Rural Affairs 2010). Mean energy intake equated 
12, 385 kJ.  
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4.3.5 Statistical analysis 
The statistical analysis for this study was performed using SPSS (Ver.19). All data are 
reported as Mean ± SD. For both the EP and RP periods, V̇̇O2, RER and EE minute 
averages were determined for each participant, whilst for the SP period data were 
collected as 30 min averages for each trial hour. The latter values were subsequently 
multiplied by 2 to provide an estimate of hourly V̇O2, RER and EE. Data were also 
analysed for the RP and SP periods combined to give a total EPOC. Each of these 
trial segments were analysed separately using repeated measures ANOVA. Where 
appropriate, data was analysed using AUC which was calculated using the trapezoid 
method (Matthews et al. 1990). No differences were found between mean and AUC 
data and therefore AUC data is not reported. Where significant differences were found 
a Bonferroni post-hoc test was used to identify where significant differences lay. For 
all analyses alpha was set at 5 %. 
 
4.4 Results 
4.4.1 Participant and exercise characteristics 
The physical characteristics of the study participants are summarised in Table 4.1. 
The average workload undertaken by study participants to elicit 90 % of peak HR 
during exercise within HIT1 was 204 ± 47 W. Similarly, the average workload 
completed to elicit 85 % of V̇O2peak during HIT2 was 211 ± 46 W. 
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Table 4.1 Participant characteristics. Data are presented as mean and (standard     
deviation).  
 
 
4.4.2 Energy expenditure  
When analysing EE for the entire trial period (combining EP, RP and SP phases) 
revealed significant differences were observed between experimental conditions (p < 
0.001). The total energy expended within HIT2 (7280 ± 703 kJ) was significantly higher 
than that expended in both HIT1 (5761 ± 598 kJ; p < 0.001) and CON (4874 ± 456 kJ; 
p < 0.001). Energy expenditure in HIT1 was also significantly higher than CON (p < 
0.001). Figure 4.2a illustrates the EE during the EP independently. Within this period 
one-way ANOVA revealed a significant difference between trials (p < 0.001). 
Specifically, EE during the EP in HIT2 (2788 ± 322 kJ) was significantly greater than 
HIT1 (1151 ± 205 kJ; p < 0.001). Logically, the EE in both exercise conditions during 
the EP was higher than CON (368 ± 46 kJ; p < 0.001). 
  
 Mean Minimum Maximum 
Age (yr) 21 (2) 19 24 
Height (cm) 181.2 (7.5) 172.1 192 
Weight (kg) 73.9 (7.5) 61.6 88.2 
Body Mass Index (kg.m-2) 22.5 (1.8) 20.3 25.0 
V̇O2Peak (ml.kg.min-1) 44 (6) 33 58 
RMR (kJ.day-1) 8629 (636) 7478 9655 
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Figure 4.2. Energy expenditure (Mean ± SD) during the a) Exercise Period b) EPOC 
Figure 4.2 Energy Expenditure (Mean ± SD) during the a) Exercise Period, b) EPOC     
Rapid Phase c) EPOC Slow Phase d) EPOC Rapid and Slow Phases Combined across 
all trials. 
 
 
Figure 4.2 b) shows the EE during the EPOC RP across main trials. One-way ANOVA 
revealed a significant difference between trials for the EPOC RP (p < 0.001). 
Specifically, the EE for this period after HIT1 (388 ± 44 kJ) was significantly higher 
than that expended over the same period during CON (329 ± 39 kJ; p = 0.02). Similarly, 
EE during the RP in HIT2 (389 ± 39 kJ) was also higher than CON (p = 0.01). During 
this period there was no difference in EE between exercise conditions. Figure 4.2 c) 
illustrates the EE during the EPOC SP across main trials. Within this period one-way 
ANOVA found no differences between experimental trials. Energy expenditure during 
* * 
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the SP was 4107 ± 387, 4227 ± 426, and 4268 ± 389 kJ for CON, HIT1 and HIT2, 
respectively. When the total EPOC period was analysed together (RP & SP combined) 
significant differences between experimental trials were evident with total EE of 4437 
± 419, 4615 ± 457 and 4658 ± 421 kJ for CON, HIT1 and HIT2 (Figure 4.2 d).  
 
4.4.3 Respiratory exchange ratio  
There was a significant difference in the RER during the RP after exercise (p < 0.001).  
In the RP RER was significantly lower in HIT1 (0.78 ± 0.06; p = 0.011) and HIT2 (0.76 
± 0.04; p = 0.004) compared with that over the same period during CON (0.87 ± 0.06). 
There were no significant differences between HIT1 and HIT2 with respect to RER in 
this period. Within the SP there were no significant differences in RER between any 
experimental trials. Furthermore, this was also the case when extending the analysis 
to include the RP period component i.e. RP & SP combined. 
 
4.5 Discussion 
The primary aim of this study was to profile the energy expended during, and for up to 
11 hours after 2 routinely used HIIE protocols. This study demonstrated that both HIIE 
interventions substantially raise EE during exertion and additionally increase EE and 
reduce RER for up to one hour after. Following this point however, no differences in 
EE or RER are apparent. These findings demonstrated that the impact of these 
protocols on EE and RER after exercise is transient, with effects on EE particularly 
being of relatively small magnitude. These data suggest that HIIE induced changes in 
post-exercise metabolic rate do not contribute significantly to previously documented 
reductions in body fat and/or waist circumference which have been observed after HIT 
interventions. 
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In the present study both HIT1 and HIT2 substantially raised EE during exertion. The 
EE elicited by the protocols implemented in this study were substantially higher than 
that induced by classical SIT training. Specifically, two recent studies have identified 
similar EE profiles during sessions of SIT with values of 595 kJ (Deighton et al. 2012) 
and 735 kJ (Hazell et al. 2012). Comparatively, both protocols utilised in the present 
investigation elicited substantially higher EE values compared with these previous 
studies, approximating two-fold higher with HIT1 and 4-4.5 fold higher with HIT2. 
These findings are of practical importance with the indication that these forms of 
training may convey dual benefit by enhancing metabolic health parameters whilst also 
exerting a noteworthy influence on energy balance. Such information begins to allow 
us to make judgements regarding the most appropriate forms of HIT suitable for 
various populations with differing intervention goals.  
 
Perhaps the most notable finding from the present investigation was that both HIT 
protocols increased EE within the hour immediately after exercise (EPOC rapid 
phase), although this response was transient and of small magnitude. Specifically, the 
net increase in EE during this period was approximately 60 kJ in both HIT 
interventions, equating to just 2 (HIT2) and 5 (HIT1) percent of the energy expended 
during the actual exercise component. The similarity in response between protocols is 
noteworthy given the marked difference in the duration and EE induced in HIT1 and 
HIT2. This is likely due to the similarity of exercise intensity between protocols, as it is 
known that exercise intensity is the most important determinant of the EPOC 
magnitude, explaining five times more of the variance than exercise duration or total 
work completed (Gore & Withers 1990).  
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The EPOC magnitude and duration in the present investigation was small and brief, 
and consequently unlikely to contribute significantly over time to changes in body 
composition and/or mass. This finding is consistent with other studies which have 
examined the effects of HIT on EPOC and reported small changes in post-exercise 
EE (Chan & Burns 2013; Williams et al. 2013; LaForgia et al. 1997) but at odds with a 
recent report which described a large increase in post-exercise EE after an acute bout 
of continuous moderate intensity cycling (Knab et al. 2011). This latter investigation is 
noteworthy given the gold standard methodology employed. Specifically, post-
exercise metabolic rate was measured after 45 min of moderate intensity cycling (~ 
73 % V̇O2max,) in a respiratory chamber over an extended duration and the researchers 
reported a 795 kJ net increase in EE over 14.2 h. At first glance, when specifically 
compared with HIT2 in the present study, it is unclear why such different outcomes 
are apparent given that the exercise intensity in HIT2 was significantly greater and 
associated EE comparable. Closer scrutiny of the study protocol however reveals one 
key difference between study methodologies. Notably, in the study conducted by Knab 
et al (2011) participants were fed back the energy which they expended during 
exercise (2171 kJ) so that they consumed a much greater amount of food on the 
exercise trial than their control trial. This extra energy would have significantly 
augmented resting metabolism (thermic effect of feeding) above that on the control 
trial and therefore the EPOC reported reflects the true increase with exercise plus the 
increase promoted by a heightened food intake. Conversely, in the present 
investigation participants consumed identical meals across trials and therefore the 
independent effect of exercise was isolated. 
 
In the current study EE was higher only during the RP of EPOC i.e. up to one hour 
after the end of exercise. This outcome is consistent with other studies which have 
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examined the impact of HIT on post-exercise metabolic rate (Chan & Burns 2013; 
Williams et al. 2013). Specifically, Chan & Burns (2013) observed an increase in 
oxygen consumption up to 30 min after SIT. Moreover, with a similar protocol, Williams 
et al (2013) observed an increase in post-exercise oxygen consumption that lasted for 
up to 45 min. These findings, and those from HIT1 in the present investigation, are 
consistent with the suggestion that brief intense exercise impacts up on the EPOC 
early response, but that more significant and prolonged exercise is necessary to 
influence more prolonged changes in metabolic rate (LaForgia et al. 2006). The brevity 
of response, particularly with regards HIT2 in the present study, is not entirely clear 
given the longer protocol duration and relatively large associated EE. It is possible that 
the intermittent nature of the protocol attenuated the associated stress and 
physiological burden however other studies utilising intermittent protocols have 
documented significantly longer EPOC durations (Bahr et al. 1992; LaForgia et al. 
1997). Both previous investigations involved supra-maximal exercise, suggesting that 
the higher exercise intensity is significant contributing factor. Furthermore, the post-
exercise EE assessment protocols were very different compared to the current 
investigation with significantly lower sampling volume and hence greater interpolation 
of data. 
 
In the present study both exercise protocols had a significant impact on the RER during 
exercise and within the EPOC RP.  Specifically, during exercise the RER increased in 
each protocol representing an increasing reliance on carbohydrate oxidation 
proportionate with the high exercise intensity. Subsequently, within the immediate hour 
after exercise, RER decreased dramatically, indicating an enhancement of fat 
oxidation within the immediate hour after exercise. This response was transient 
however in the current study as participants consumed a breakfast meal one hour after 
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exercise and the resultant switch in metabolic fuel preference masked any more 
prolonged enhancement of fat oxidation which may otherwise have occurred. 
Specifically, other investigations have shown that lower RER values may persist for 
several hours after interval type exercise (McGarvey et al. 2005; Malatesta et al. 
2008). The mechanisms responsible for this change in metabolism possibly include 
an elevated catecholamine response to HIT, which may stimulate mitochondrial 
respiration, lipolysis and fat oxidation (Mulla et al. 2000). An increase in CO2 retention 
as a means of replenishing the bicarbonate used to buffer lactic acid (Bahr et al. 1987, 
1991a, 1991b, 1992; Short and Sedlock 1997; LaForgia et al. 2006) may also be 
important. Nonetheless, given the relatively small absolute increase in EE the 
importance of this change in fuel preference is debatable. 
 
This investigation has strengths and limitations which should be recognised. Firstly, 
the strict control of diet and physical activity, prior to and during the investigation, is a 
key strength of the study. Moreover, the detail of post-exercise assessment in terms 
of the percentage of actual sampling time, rather than data interpolation, is also 
notable (51 % of the total 11 h EPOC assessment). Limitations of this study include 
the lack of generalisability afforded by the use of a homogenous sample of young, 
healthy males. There would be merit in future studies to examine the impact of HIIE 
on EPOC in individuals who are obese whereby changes in post-exercise metabolic 
rate may make a greater relative contribution to the overall energy deficit imposed by 
exercise. Sex based differences in metabolism and energy homeostasis also demand 
that investigations are conducted with females. 
 
Based on the results obtained from the current study it may be suggest that the EE 
attributed to EPOC is minimal when compared against a resting control trial and that 
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this is likely not to be the reason for the previously documented fat loss associated 
with HIT training programmes (Boutcher 2011). From the evidence presented here it 
would suggest that HIT based exercise does not stimulate an elevation in metabolic 
rate that would be effective in contributing to fat loss over brief interventions. There 
are likely further un-elucidated mechanisms contributing to reductions in body fat 
and/or waist circumference following HIT based exercise.  
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5CHAPTER 5 
 
 
 
AN EVALUATION OF LOW AND REDUCED VOLUME 
HIGH INTENSITY INTERMITTENT TRAINING (HIT) 
FOR HEALTH IMPROVEMENTS IN THE OBESE 
 
 
2 This chapter has been submitted for publication and is currently under review. 
                                            
2 Kelly BM, King JA, Jackson AP, Xenophontos S, Nimmo MA (2014) Two weeks of 
low-volume high intensity training has no impact on key determinants of metabolic 
health in pre-clinical populations. Appl Physiol Nutr Metab. Submitted.  
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5.1 Abstract 
HIT type training has been described as a time-efficient strategy for inducing 
favourable cardiorespiratory and metabolic health adaptations. To date there has been 
little published evidence as to the efficacy of this training modality for health 
improvements within pre-clinical populations such as the obese and insulin impaired. 
Implementing a recently popularised low volume HIT protocol this chapter investigate 
the effects of 6 sessions (n = 10) or 4 session (n = 8) of HIT performed over 2 weeks 
on aerobic capacity, body composition, glycaemic control and systemic inflammation 
in an in-active overweight/obese male cohort (BMI 31.2 ± 3.6; V̇O2max 30.3 ± 4.4 ml.kg-
1.min-1). All training sessions consisted of 10 x 1 min intervals at 90% HRpeak separated 
by 1 min of active recovery with 50W resistance. After 2 weeks of training no changes 
in body mass occurred in either groups 1 (Δ = -0.1 kg; p = 0.798) or 2 (Δ = -0.2 kg; p 
= 0.524). In conjunction with no changes in lean body mass (both groups = p > 0.05) 
BMI remained un-altered in groups 1 (Δ = 0.0 kg.m2; p = 0.716) and 3 (Δ = 0.0 kg.m2; 
p = 0.537). Group 1 demonstrated a non-significant reduction in systolic blood 
pressure (Δ = -8.1 mmHg; p = 0.446), with group 2 showing a non-significant increase 
(Δ = 4.0 mmHg; p = 0.348).  After the interventions no changes were detected from 
baseline in aerobic capacity, glycaemic control or systemic inflammatory profile in 
either group (p > 0.05). It was concluded that within this pre-clinical population, the 
HIT regimens utilised within this chapter were not able to induce any changes in the 
selected health parameters within a 2 week time-frame. 
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5.2 Introduction 
In the obese, the core defect underlying the development of T2DM is skeletal muscle 
insulin resistance (DeFronzo and Tipathy 2009). Mechanisms and primary contributing 
factors of insulin resistance are complex although evidence suggests that physical 
inactivity may be a principal initiating factor (Thyfault, Krogh-Madsen 2011). Inactivity 
leads to reduced EE, and when combined with increased energy intake, promotes 
adipose tissue expansion and with it the development of obesity and a state of chronic 
inflammation (McArdle et al. 2013). Inflammation has been independently implicated 
in the development of insulin resistance and T2DM (Wellen and Hotamisligil 2005) and 
is characterised by abnormal cytokine production, increased production of acute 
phase reactants as well as activation of a network of inflammatory signalling pathways 
(Hotamisligil 2006). Regular exercise favourably influences many aspects of health 
and is particularly noted for its capacity to improve insulin sensitivity and to help 
prevent or manage T2DM (Goodyear and Kahn 1998; Sigal et al. 2006). Exercise 
prescription guidelines have been developed to help individuals realise the health 
enhancing effects of exercise which traditionally have focused on moderate-intensity, 
continuous forms of exercise (Garber et al. 2011). Unfortunately, adherence to these 
guidelines is poor (British Heart Foundation 2012), therefore many individuals do not 
perform sufficient exercise to benefit their health. Given recent evidence revealing that 
healthy individuals (Bartlett et al. 2011) and patient populations (Tjønna et al. 2008) 
may prefer intermittent over continuous exercise, and the noteworthy benefits reported 
with some novel forms of intermittent training (Gibala et al. 2012), it is timely to 
consider new forms of exercise training that may be more readily adopted and 
sustained.   
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Recent work suggests that SIT and HIT provide time-efficient strategies for inducing 
metabolic and cardiorespiratory adaptations comparable to those seen following 
traditional high volume endurance training (Burgomaster et al. 2005, 2007, 2008; 
Gibala et al. 2006; Rakobowchuk et al. 2008; Trilk et al. 2011). Notably, several groups 
have demonstrated that SIT may have favourable effects on metabolic control after as 
few as six training sessions (Babraj et al. 2009; Burgomaster et al. 2006, 2008; Gibala 
et al. 2006; Richards et al. 2010; Shepherd et al. 2013; Whyte et al. 2010) and with a 
several-fold lower time commitment. In these previous interventions it is important to 
note that SIT training was employed as opposed to HIT training. SIT training requires 
a specialised ergometer and it is likely that this challenging regimen may not be 
accomplishable for all populations. In recognition of this, a revised low-volume HIT 
protocol has been devised and has shown promise as a regimen that can be 
completed by clinical (Little et al. 2011) and pre-clinical groups (Hood et al. 2011). 
Specifically, using this adapted protocol consisting of 10 x 1 min intervals at ~ 90 % 
HRmax, a striking reduction in 24 h glycaemia was reported after two weeks (six 
sessions) in patients with T2DM (Little et al. 2011).  
 
In the present study it was specifically sought to advance the work of Hood et al (2011) 
and Little et al (2011) by characterising the impact of low-volume HIT on additional key 
determinants of metabolic health (systemic inflammation, glycaemic control, body 
composition, blood pressure, aerobic capacity) in a pre-clinical population (inactive, 
overweight or obese men). Furthermore, given previous information indicating that 
changes in aerobic capacity can be achieved with 2 sessions per week of high intensity 
exercise (within two weeks) (Wenger and Bell 1986), we also examined whether this 
reduced training frequency was sufficient to confer any favourable health adaptations. 
The importance of this latter line of enquiry lies within the identification of the minimum 
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amount of exercise capable of providing health benefits, which has implications for the 
sustainability of interventions. 
 
5.3 Materials and Methods 
5.3.1 Participant Characteristics 
Participant characteristics are provided in Table 5.1. All participants had a BMI  27 
kg·m-2, were inactive (no structured exercise), but were otherwise healthy. Participants 
were excluded if they were smokers, had impaired fasting glucose or had a BMI  40 
kg.m-2. Participants were included in the study after they were informed both verbally 
and in writing of all possible discomforts and risks associated with the study. All study 
procedures were approved by the local ethics advisory committee and all participants 
gave their written informed consent before commencing the study. 
 
5.3.2 Study assessments (Pre and 72 h Post-Training) 
Arterial blood pressure was measured using a digital automatic blood pressure monitor 
(Omron M7, Omron Healthcare Ltd, Milton Keynes, UK) as described in general 
methods. Body mass and height were measured with participants wearing shorts.  
Body composition parameters including height, weight, waist and hip circumferences 
and DEXA were carried out as described in general methods. 
 
Peak oxygen uptake (V̇O2peak) was determined using a continuous incremental 
exercise test on an electromagnetically-braked cycle ergometer (Lode Excalibur, 
Groningen, The Netherlands) performed to volitional exhaustion. Expired air was 
measured continuously using an online breath-by-breath gas analysis system (Cortex 
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Metalyzer, CPX International Inc, Berlin, Germany). This differed from the collection 
methods in the previous chapter due to new testing equipment and the collection of 
individual breath data as opposed to 5 s averages. Participants warmed up for 3 min 
against a resistance of 50 W, after which point the workload increased by 30 W every 
3 min from an individualised starting load. The test was terminated when the 
participant could no longer maintain 50 pedal revolutions per min (RPM). V̇O2peak was 
identified over the highest 30 s period during the test. Heart rate (HR) was measured 
throughout the test using a telemetric HR monitor, which was wirelessly paired with 
the breath-by-breath analysis system (Polar RS100, Polar Electro, UK Ltd, Warwick, 
UK).  Glycaemic control and insulin sensitivity were assessed via OGTT (See General 
Methods for detail). 
 
5.3.3 High intensity interval training  
The HIT protocol utilised in this study was based on that devised by Little and 
colleagues (2011) (see general methods for detail). Group 1 (n = 8) completed six 
sessions of HIT exercise over 2 weeks whereas group 2 (n = 10) completed four 
sessions over the same period. Group one trained on Monday, Wednesday and 
Friday. Group 2 trained on a Monday and Friday. 
 
5.3.4 Dietary and physical activity controls 
Before the intervention participants were explicitly told not to change their dietary 
habits or undertake any structured exercise during the course of the study. Prior to the 
pre-training assessments participants recorded their diets and subsequently replicated 
this before the post-training assessments.  
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5.3.5 Biochemical Analysis 
Biochemical analysis of inflammatory mediators was carried out as described in 
general methods. All samples were analysed in duplicate and were repeated if the CV 
between duplicates was more than 10 %. The intra-assay CVs for the inflammatory 
proteins were as follows: adiponectin 3.5 %, IL-10 8.7 %, TNFα 7.8 %, CRP 5.3 %, IL-
6 4.8 %, sIL6-R 3.9 % and MCP-1 6.4 %. 
 
5.3.6 Statistical analysis 
Statistical analysis was carried as described in general methods. Specifically insulin 
sensitivity was determined by the ISI calculated using the OGTT glucose and insulin 
values from the formula proposed by Matsuda and DeFronzo (1999). Pre to post 
differences in basal plasma glucose, insulin, ISI anthropometry and V̇O2peak were 
assessed using paired sample t-tests. Additionally, group differences were assessed 
via comparison of delta change using independent t-test. To be included in the 
analysis participants must have completed all of the necessary training sessions. 
 
5.4 Results 
5.4.1 Body composition, blood pressure and peak oxygen uptake 
There were no differences in any characteristic between group 1 and 2 at baseline 
(Table 5.1). Following six sessions of HIT over 2 weeks (group 1) there were no 
changes in blood pressure, aerobic capacity, body mass, BMI, waist or hip 
circumference (Table 5.1). Moreover, DEXA indicated no differences in regional fat 
(%), total tissue, total lean tissue, total fat tissue or BMC (all p > 0.05) (Figure 5.1 a). 
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This lack of change was replicated in group 2 who completed 4 sessions of HIT over 
two weeks (Figure 5.1 b). 
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Table 5.1 Body composition, blood pressure and peak oxygen uptake for groups 1 and 2 pre and post 2 weeks of HIT. 
 
 
 
 Group 1  Group 2  
 Pre-Training Post-Training p Pre-Training Post-Training p 
 Mean (SD) Mean (SD) Sig. < 0.05 Mean (SD) Mean (SD) Sig. < 0.05 
Body Mass (kg) 94.5 (13.9) 94.4 (14.3) 0.798 104.8 (17.6) 104.6 (17.0) 0.524 
BMI (kg.m2) 29.7 (3.4) 29.7 (3.5) 0.716 32.3 (3.3) 32.3 (3.2) 0.557 
Waist Circumference (cm) 110.4 (9.7) 95.3 (4.4) 0.164 109.6 (10.4) 108.6 (10.4) 0.316 
Hip Circumference (cm) 107.6 (6.9) 104.0 (2.6) 0.235 113.9 (7.3) 112.7 (9.4) 0.499 
Waist-to-hip ratio 0.9 (0.03) 0.9 (0.03) 0.709 1.0 (0.05) 1.0 (0.03) 0.879 
Systolic BP (mmHg) 131.1 (16.8) 123.0 (11.5) 0.446 120.6 (8.9) 124.0 (5.9) 0.348 
Diastolic BP (mmHg) 84.7 (10.9) 76.0 (9.7) 0.185 76.8 (7.1) 75.8 (5.4) 0.829 
V̇O2peak (l.min-1) 3.1 (0.6) 3.7 (0.8) 0.138 3.2 (0.4) 3.2 (0.4) 0.846 
V̇O2peak (ml.kg-1.min-1) 35.6 (5.4) 38.5 (5.4) 0.135 30.3 (4.2) 30.5 (4.2) 0.960 
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Figure 5.1 Body composition changes as measured by DEXA represented as % change.  
a) represents individuals having completed 4 HIT sessions over 2 weeks 
with b) representing those individuals having completed 6 HIT sessions 
over 2 weeks. 
 
5.4.2 Systemic inflammation and insulin sensitivity 
Table 5.2 shows the circulating concentrations of candidate inflammatory proteins 
before and after training. There were no differences seen within or between groups in 
any parameter (all p > 0.05). There were also no differences found for fasting or 2 h 
(OGTT) insulin or glucose AUC (p > 0.05) in either group. Consequently, ISI also 
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remained unaltered. The glucose and insulin responses to the 2 h OGTT before and 
after training are shown in Figure 5.2. 
 
 
Figure 5.2 Two hour OGTT response to 75 g glucose ingestion with data representing 
group 1 glucose (a) and insulin (b) responses and group 2 glucose (c) and 
insulin (d) responses. Data are presented as mean and standard deviation. 
Solid lines represent pre-intervention with dashed lines representing 
responses 72h post training. 
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Table 5.2 - Inflammatory proteins in the circulation in groups 1 and 2 following 2 weeks of HIT training. Data presented as range and 
(median). 
 
  Group 1   Group 2   
 Typical 
Ranges 
Pre-Training Post-Training  P Pre-Training Post-Training  p 
  Range (Median) Range (Median) Mean ∆Change Sig. < 0.05 Range (Median) Range (Median) Mean ∆Change Sig. < 0.05 
Adiponectin (µg.ml-1) 2.0-20.0 1.1-14.6 (2.3) 0.8-10.9 (1.7) -0.3 0.123 0.6-8.3 (2.2) 0.5-7.6 (1.9) -2.0 0.158 
IL-10 (pg.ml-1) 1.1-4.5 0.5-0.7 (0.5) 0.5-0.7 (0.5) -0.03 0.304 0.4-0.8 (0.5) 0.5-1.0 (0.5) -0.05 0.337 
TNF-α (pg.ml-1) 1.3-2.3 1.4-2.6 (2.3) 1.1-3.2 (2.2) -0.02 0.903 1.7-4.9 (2.5) 1.7-4.4 (2.5) -5.4 0.704 
CRP (µg.ml-1) 1.4-5.8 0.1-5.7 (1.5) 0.1-3.8 (1.5) -0.3 0.358 0.2-4.0 (1.1) 0.1-3.6 (0.6) -0.4 0.067 
IL-6 (pg.ml-1) 1.0-6.0 1.6-112.4 
(3.5) 
1.3-87.0     
(3.7) 
-9.0 0.111 1.0-11.1 (2.8) 1.2-8.4 (2.6) -0.5 0.182 
sIL-6R (ng.ml-1) 20.0-45.0 21.3-36.3 
(24.8) 
19.8-32.3 
(27.9) 
1.2 0.518 21.7-51.0 
(25.1) 
23.6-65.3 
(30.7) 
4.2 0.246 
MCP-1 (pg.ml-1) 100.0-200.0 51.4-411.1 
(157.3) 
55.8-181.0 
(148.2) 
-38.7 0.255 107.4-246.3 
(143.5) 
65.5-255.6 
(141.3) 
0.5 0.976 
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5.5 Discussion 
This investigation examined the impact of low-volume HIT on key metabolic health 
parameters (systemic inflammation, glycaemic regulation, body composition, aerobic 
capacity) using a recently popularised protocol that has shown promise as a 
therapeutic intervention in clinical and pre-clinical groups (Hood et al. 2011; Little et 
al. 2011). Moreover, it was sought to determine whether any benefits would be 
obtainable with a reduced training frequency of two times per week. The novel findings 
in this study were that this specific regimen (training two or three times each week) 
was unable to induce changes within these selected health parameters after two 
weeks in a population at risk of developing chronic metabolic disease.  These findings 
suggest that this protocol is not potent enough to stimulate certain metabolic health 
adaptations within this population and time-frame. 
 
Exercise of varying intensities improves wellbeing and can combat some of the basal 
increase in inflammation often associated with obesity, T2DM and cardiovascular 
disease (Adamopoulos et al. 2002; Balducci et al. 2010; Leggate et al. 2012; 
Thompson et al. 2010; Zoppini et al. 2006).  At present, there is a scarcity of data 
regarding the impact of HIT on inflammation. With regards to exercise per se, the 
consensus of evidence suggests that high intensity exercise is needed to reduce the 
inflammatory profile (Gleeson et al. 2011; Nimmo et al. 2013). This thesis was 
supported by a large intervention in T2DM patients where robust improvements in the 
circulating inflammatory profile were constrained to those who performed combined 
high intensity aerobic and resistance exercise training (Balducci et al. 2010). The 
findings in the present investigation are at odds with those previously reported 
whereby two weeks of HIT improved the inflammatory profile in subcutaneous adipose 
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tissue and the circulation (Leggate et al. 2012). In this previous study however, the 
HIT regimen differed; despite eliciting a similar intensity, required a four-fold greater 
exercise volume than the protocol implemented in the present investigation. Within a 
2 week time-frame, it therefore appears that a greater volume of HIT is required to 
impact up on systemic inflammatory status at this intensity.  
 
Inflammation has been independently implicated in the development of insulin 
resistance and T2DM (Wellen and Hotamisligil 2005). Inflammatory mediators 
promote insulin resistance through inhibitory serine phosphorylation of IRS-1 which 
disrupts insulin-receptor signalling through several distinct mechanisms; ultimately 
blocking insulin action (Zhang et al. 2010). The novel aspect of the present 
investigation was the characterisation of this modified low-volume HIT protocol in a 
population with a less extreme phenotype who are at risk, rather than already 
exhibiting chronic metabolic disease. This study also sought to provide new 
information regarding exercise frequency; specifically whether benefits in glycaemic 
control could be achieved with two rather than three bouts of HIT each week.  
 
In the present investigation there were no measurable changes in fasting glucose or 
insulin following two weeks of HIT, with either two or three training sessions performed 
per week. Given that fasting levels of these parameters chiefly reflect the hepatic 
contribution to glycaemic regulation, these data indicate that HIT did not affect hepatic 
glycaemic control. This outcome is supported by the results from two previous studies 
that have shown no alteration in fasting levels of glucose and insulin after two weeks 
of SIT (Babraj et al. 2009; Richards et al. 2010). Conversely, implementing the same 
low-volume HIT protocol as per the present investigation, Hood and colleagues (2011) 
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observed a 16 % decrease in fasting levels of insulin. The reason for the difference 
between the present results and those reported by Hood et al (2011) is not clear given 
the high similarity in protocols and participants studied. Additional confirmatory work 
with a larger participant cohort is therefore required. 
 
The present study also found no changes in the OGTT glucose and insulin responses 
following the intervention. It therefore also appears that in this population, this specific 
low-volume HIT regimen does not alter glucose profile after 4 or 6 training sessions. 
In similar cohorts, beneficial changes in glucose profile have been reported previously 
after two weeks with the classical SIT protocol when assessments have been made 
with the euglycaemic-hyperinsulinemic clamp (Richards et al. 2010) or OGTT (Babraj 
et al. 2009). The difference in outcome between protocols is possibly related to the 
greater breakdown of muscle glycogen and increase in GLUT4 transport proteins in 
response to SIT. Despite the lack of effect observed in the present study, previous 
research suggests that this low-volume HIT protocol may provide robust 
improvements in postprandial glycaemic regulation within T2DM patients who exhibit 
a more deleterious glycaemic profile (Little et al. 2011). Notably, these improvements 
were detected using continuous glucose monitors which may detect changes not 
identified by OGTT (Karstoft et al. 2013).  
 
The present investigation is the first to examine the impact of low-volume HIT on 
aerobic capacity. After 2 weeks, neither 6 (group 1) or 4 (group 2) sessions of HIT 
altered peak oxygen uptake in this pre-clinical group who exhibited low baseline levels 
of aerobic fitness. In several previous investigations implementing SIT, changes in 
aerobic capacity have not directly been examined. Instead, improvements after 2 
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weeks of training have been inferred by reductions in time-trial performance tests and 
changes in skeletal muscle markers of oxidative capacity (Burgomaster et al. 2006; 
2007; Gibala et al. 2006). Additionally, high-volume HIT protocols have been shown 
to markedly improve aerobic capacity after 2 weeks in healthy women (13 %) (Talanian 
etal.2007), and overweight/obese men (12 %) (Leggate et al. 2012). The differences 
in findings between studies relate directly to the protocols implemented and probably 
relate to the time spent exercising at V̇O2max (Billat et al. 2000). Un-reported data from 
Chapter 4 shows that within healthy untrained males, only a fraction of time is spent 
close to peak oxygen uptake intensity. This contrasts with SIT and high-volume HIT 
where large percentages of the exercise intervals are completed at or above this 
required intensity (Leggate et al. 2012). 
 
The current study is the first to incorporate both standard anthropometric measures 
and DEXA analysis before and after a two week HIT intervention. No changes were 
detected for group 1 or 2 in total body mass, waist or hip circumferences or waist-to-
hip ratio. Furthermore, no changes were detected in tissue fat percentage, regional fat 
percentage, fat mass, lean mass or BMC. These outcomes demonstrate that across 
this duration, this HIT protocol did not exert any influence on any body composition 
parameter. In contrast to these findings, improvements in body composition have been 
reported in response to SIT (Whyte et al. 2010) and high-volume HIT (Leggate et al. 
2012) interventions after 2 weeks with reductions in waist circumference being 
recorded (up to 2.4 cm). Given the relatively low associated total energy deficits 
imposed by these regimens (Hazell et al. 2012; Leggate et al. 2012; Kelly et al. 2013) 
it is hard to explain these outcomes. The inherent variability associated with this 
measurement may have been influential.  
 97 
 
A growing body of data indicates that longer interval training based interventions (3-6 
months) may provoke changes in body composition (Gillen et al. 2013; Nybo et al. 
2010; Schjerve et al. 2008; Tjønna et al. 2008; Warburton et al. 2005). Specifically, 
within a sample of overweight women, Gillen et al (2013) showed that 6 weeks of low-
volume HIT reduced adiposity (total body, abdominal and leg) and increased lean 
mass (leg and gynoid regions). Collectively these data suggest that 2 weeks of low-
volume HIT is not sufficient to stimulate changes in body composition, however 
favourable changes to fat and lean mass may occur if the regimen is extended to 6 
weeks or more.  
 
In conclusion, research has shown that HIT can favourably affect many aspects of 
health with some beneficial changes being achievable within as little as two weeks 
(Babraj et al; 2009; Hood et al. 2011; Little et al. 2011; Richards et al. 2010; Talanian 
et al. 2007; Whyte et al. 2010).  The current chapter sought to provide new information 
concerning a recently popularised low-volume HIT protocol that has been deemed 
more suitable for clinical and pre-clinical populations. Despite previous findings 
showing reduced fasting insulin in sedentary overweight individuals, and attenuated 
24 h glycaemia in patients with T2DM, this study failed to observe any changes in 
systemic inflammation, glycaemic control, body composition or aerobic capacity in 
inactive, overweight or obese men. A lack of change was also witnessed in a second 
arm of participants who reduced the training frequency from 3 to 2 bouts per week. 
This study has therefore shown that this particular low-volume HIT protocol was 
unable to exert any beneficial impact on selected health indicators within this time-
frame and pre-clinical population.  
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6CHAPTER 6 
 
 
 
GLYCAEMIC CONTROL AND INFLAMMATION IN 
RESPONSE TO 6 WEEKS OF HIGH INTENSITY 
INTERVAL TRAINING IN THE OBESE 
 
3 The study in the present chapter was part of a large international collaborative project 
(The Metapredict Trial, EU FP7) and was a sub-study specifically focussed on 
inflammation and adipose tissue biology with data representing ~ 10 % of the total 
project cohort. The author contributed significantly to all elements of study design and 
independently led this sub-study. 
  
                                            
3 WWW.METAPREDICT.EU 
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6.1 Abstract 
HIT training may act as a novel approach in the treatment of obesity induced cardio-
metabolic co-morbidities. The current study assessed the impact of 6 weeks of HIT 
training within an obese cohort. Specifically this study focused on the potential 
therapeutic benefits of HIT for improving inflammatory status, glucose control, aerobic 
capacity and body composition. Eighteen participants (10 men and 8 women) aged 18 
- 50 years all with a BMI > 27 kg·m-2 successfully completed the study. Fasting, rested 
blood samples were collected before and 48 h after the final training session with 
analysis of inflammatory mediators (Adiponectin, MCP-1, IL-10, TNF-α, IL-6, sIL-6R, 
and CRP) carried out by ELISA.   Pre and post adipose tissue biopsies were collected 
for analysis of local inflammatory gene expression (CD46, CD68, HIF1- α, HMOX-1, 
IL-6, IL-6R, IL-10, ITGAX, MRC-1 and TNF-α) using real time QPCR. Body 
composition was measured  (DEXA) with glycaemic control and aerobic capacity also 
determined. Results demonstrated significant improvements in maximal aerobic 
capacity after training (p ≤ 0.05) as well as significant up-regulation of genes encoding 
for the M2 macrophage phenotype (p ≤ 0.05). No further physiologically significant 
changes were demonstrated.  This study demonstrated that HIT based training 
induced significant improvements in maximal aerobic capacity with an obese cohort 
however was not able to improve glucose control or systemic inflammation. This study 
provides some evidence that HIT training may produce a localised anti-inflammatory 
environment within adipose tissue however more work is required in order to fully 
elucidate if this response. 
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6.2 Introduction 
The previous chapter suggested that a sub-maximal HIT training intervention (Little et 
al. 2011) was unsuccessful in improving markers of aerobic capacity, metabolic 
control, body composition or inflammatory profile when performed over a 2 week 
period. This gave rise to the conjecture that if extended over a longer training period 
in order to increase total accumulated training volume, it may have be possible for a 
modified model (Little et al. 2011) of HIT to improve the previously measured 
physiological factors whilst still being ‘manageable’ within an obese cohort. 
 
This chapter focused particularly on the gene expression of inflammatory mediators 
and other factors influencing metabolic regulation. Although expression of mRNA only 
explains ~ 40 % of protein abundance, the abundance of mRNA is often an excellent 
proxy for the presence of a protein, specifically, whether or not that protein is 
detectable within target cells (Ramakrishnan et al. 2009; Vogel and Marcotte 2012).  
 
HIT type training has been shown to act as a potent stimulus for the up regulation 
mRNA in as little as 2 wks. Using an AIT protocol described previously (Leggate et al. 
2012), Perry and colleagues (2010) demonstrated that PGC-1α mRNA was increased 
>10-fold 4 h after the 1st training session and returned to baseline within 24 h. This 
‘saw-tooth’ pattern continued until the 7th training session, with smaller increases after 
each bout. In contrast, PGC-1α protein was increased 24 h after the 1st bout (23 %) 
and plateaued at +30 – 40% between the 3rd and 7th training session. It was 
demonstrated that the training-induced increases in transcriptional and mitochondrial 
proteins resulted from the cumulative effects of transient bursts in their mRNAs. From 
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this work it was summarised that the transcriptional capacity of human muscle is 
extremely sensitive and can be activated by just one training bout. 
 
In continuation from the above, it may also be possible to use mRNA concentrations 
as an estimate of potential proteomic changes over time with longer term HIT exercise 
because of their earlier response. In addition, given the importance of adipose tissue 
as an endocrine organ and its relationship with metabolic homeostasis, tissue specific 
mRNA was assessed in order to address localised changes in mediators of metabolic 
regulation and inflammation as well as direct changes in the circulation. Inflammatory 
proteins were measured in the circulation in order to ascertain the direct systemic 
effects of HIT exercise on chronic inflammation. 
 
The exercise period was extended to 6 weeks. This duration was derived from the 
work of Burgomaster et al (2008) who demonstrated significant improvement in V̇O2max 
following 6 weeks of SIT training although the SIT training group indicated significant 
improvements in aerobic capacity between 0 and 3 weeks with no further 
improvements beyond week 3. This data suggests that the critical maximum HIT 
training programme length probably lies around 3 weeks. The intensity in this study 
was > 100 % V̇O2max.  At a lower intensity and in an obese group six weeks of training 
has shown health benefits (Larsen et al. 2014). The training was based around the 
use of 1 min intervals devised by previous groups and the previous chapter (Little et 
al. 2011). The modification is around the recovery (increased from 60 s to 90 s) and in 
the training intensity of the active component which was identified at the first training 
session in week 1. It was determined as the maximal wattage that the subjects could 
sustain for 60 s whilst maintaining an RPM of 100, which on average corresponded to 
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128 % of the maximal wattage achieved during an incremental cycling test. 
Participants performed a maximum of 3 reps in week 1, increasing to 5 reps in weeks 
2 which was maintained then throughout training. After the first 2 weeks, the training 
load was increased by 10 %. Along with significant increases in lean mass and V̇O2peak 
the authors describe a significant decrease in HbA1c levels. This 6 week protocol 
(Larsen et al. 2014) was sufficient in improving markers of metabolic stability and adds 
further justification for employing a 6 week intervention when incorporating sub-
maximal HIT training. 
 
The aim of this chapter was to extend the training programme to 6 weeks and to modify 
the protocol to one more closely linked to Larsen et al. (2014). It was expected that 
positive improvements in glucose control, inflammation, body composition and V̇O2peak 
would occur as a consequence of 6 weeks HIT training at both the mRNA and protein 
levels.  
 
6.3 Materials and methods 
6.3.1 Participant characteristics 
All participants had a BMI > 27 kg·m-2, reported not taking part in any form of exercise 
more than 2 times per week and were otherwise healthy. Participants were excluded 
if they were smokers or had a BMI  40 kg.m-2. Participants were included in the study 
after they were informed both verbally and in writing of all possible discomforts and 
risks associated with the study. All study procedures were submitted to and approved 
by the local ethics advisory committee and all participants gave their written informed 
consent before commencing the study. 
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6.3.2 Body composition  
Approximately 8 days after initial baseline monitoring, participants entered the 
laboratory at 7 am following a 10 h overnight fast. Firstly body composition was 
analysed using DEXA (Lunar Prodigy, GE medical systems, Madison, WI, USA) (See 
general methods for detail). Activity EE was monitored throughout the study using the 
Acti-heart accelerometer (Mini Mitter, Sunriver, OR, USA). The measurement of 
physical activity prior to training, over a 7 day period allowed for estimation of typical 
daily total energy expenditures. The Acti-heart has been shown to provide accurate 
estimates of energy expenditures in low-to-moderate activities (Thompson et al. 2006), 
as well as treadmill walking and running in adults (Brage et al. 2005) with currently no 
data specific to its use within the obese cohort. 
 
The Acti-heart was attached to participants chests using ECG electrodes (3M Red Dot 
2271, London, Ontario, Canada), positioned at the level of the third intercostal space. 
Once a suitable position was confirmed by signal test, the Acti-heart was set to record 
data every 30 s over a 7 day period.  
 
Energy intake was assessed via a standard 4-day diet diary, incorporating 3 week-
days and 1 weekend day in order to estimate average daily energy intake (Thompson 
and Byers 1994). Participants were fully instructed on food weighing with digital scales 
(Salter, Kent, UK) and brand recording. Subsequent data was analysed for energy 
content via ‘micro-diet’ software (Downlee systems, High Peak, UK).  
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6.3.3 Adipose tissue sampling 
Following assessment of body composition participants moved to a sterile lab for 
adipose tissue biopsy. Participants lay in a semi-supine position and povidone-iodine 
was used to clean the inferior border of the costal margin to the superior iliac spine. 
10 ml of 1 % (w/v) lidocaine was administered under sterile conditions to the area 
before the adipose tissue was extracted ~10 cm - 15 cm laterally from the umbilicus, 
using a percutaneous needle biopsy technique (Christiansen et al. 2010a) with a 14 
GA needle and 20 ml syringe. A vacuum was applied to the syringe resulting in the 
collection of adipose tissue. The excised adipose tissue was immediately washed with 
0.9 % (w/v) saline solution to limit blood levels within the biopsy sample before it was 
aliquoted into Eppendorf tubes using sterile forceps. The tissue was snap frozen in 
liquid nitrogen before being transferred to - 80 °C freezer until analysis. 
 
6.3.4 Oral glucose tolerance test 
Participants were prepared for an oral glucose tolerance test which was completed 
over a 2 h period (see general methods for detail). Immediately prior to OGTT testing 
and following 10 min of seated rest, blood pressure was measured (See general 
methods for detail). 
 
6.3.5 Test of peak aerobic capacity 
Twenty-four hours after body composition, biopsy and OGTT tests, participants 
returned to the laboratory to complete a V̇O2peak test. Participants had V̇O2peak 
determined using a continuous incremental exercise test on an electromagnetically-
braked cycle ergometer (Lode Excalibur, Groningen, The Netherlands), performed to 
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volitional exhaustion. This test differs from that described in previous chapters. Expired 
air was measured continuously using an online breath-by-breath gas analysis system 
(Cortex Metalyzer, CPX International Inc., Berlin, Germany). Participants warmed up 
for 5 min against a resistance of 50 W, after which point the workload was increased 
linearly by 16 W per minute until the participant could no longer maintain 50 RPM. This 
protocol differs from the step protocols utilised in previous chapters. V̇O2peak was 
identified over the highest value achieved over 15 breaths, taken from a rolling 
average. HR was measured throughout the test using a telemetric heart rate monitor, 
which was wirelessly paired with the breath-by-breath analysis system (Polar RS100, 
Polar Electro, UK Ltd, Warwick, England).  
 
6.3.6 Repeat baseline tests 
On completion of the V̇O2peak test participants were once again fitted with an Acti-heart 
monitor and provided with 4-day diet diary apparatus. Participants maintained both 
over a 7 day period which allowed for assessment of diet and physical activity stability 
when compared against the initial monitoring period measurement. On completion of 
7-day diet and activity monitoring participants returned to the laboratory at 8 am having 
fasted for 10 h overnight in order to complete validation OGTT and V̇O2peak tests. This 
allowed for the evaluation of basal glucose variability and allowed determination of any 
learning prejudice relating to the test of maximal aerobic capacity. Baseline V̇O2peak 
was taken as the highest value achieved from the 2 baseline measures. 
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Figure 6.1 Schematic representation of the experimental protocol 
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6.3.7 Post-training measurements 
At the beginning of week 3 participants were once again fitted with an Acti-heart 
monitor in order to estimate changes in habitual daily EE attributable to intervention 
administration. Post-intervention procedures were carried out 72 h after the final 
training session to abolish any effects of acute exercise (Hawley and Lessard 2008) 
and were identical to those performed during the pre-training data acquisition period, 
with Acti-heart readings collected continuously for 1 week after training. 
 
6.3.8 High intensity interval training  
Participants underwent 6 weeks of 100 % supervised training 3 x per week, with 
approximately 1–2 rest days between training days, similar to that described 
previously (Hoier et al. 2013; Larson et al. 2014). Each training session lasted for ~ 15 
min and consisted of a 2 min warm-up (50 W) followed by 5 x 60 s exercise bouts with 
90 s cycling at a low intensity as recovery (50 W). The training load was found at the 
first training session in week 1. It was determined as the maximal load that the subjects 
could sustain for 60 s, which corresponded to 100 % - 130 % of Wmax achieved during 
the incremental cycle test. After the first week of training, repetitions increased from 3 
to 5 and after the first 2 weeks the training load was increased by 10 %. Participants 
completed a total of 18 HIT training sessions. If participants were unable to complete 
a minimum of 16 sessions they were excluded from the study. If after 6 weeks, only 
16 sessions were achieved, 2 additional sessions were completed immediately 
beyond the 6 -week end point. 
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Table 6.1  Participant characteristics, with data presented as mean and (standard deviation). Abbreviations: BMI=body 
mass index, BP=blood pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Pre-Training                          Post-Training p 
    
 Mean (SD) Mean (SD) Sig*. < 0.05 
Body Mass (kg) 96.2 (17.7) 96.5 (18.2) 0.630 
BMI (kg.m2) 31.8 (3.7) 31.9 (3.8) 0.658 
Systolic BP (mmHg) 124.1 (7.4) 121.6 (9.4) 0.173 
Diastolic BP (mmHg) 79.1(6.1) 80.4 (6.9) 0.460 
V̇O2peak (L.min-1) 2.4 (0.7) 2.8 (0.8) < 0.01* 
V̇O2peak (ml.kg-1.min-1) 25.2 (4.8) 28.5 (4.8) < 0.01* 
 109 
 
6.3.9 ELISAs and biochemical analysis 
Adiponectin, MCP-1, IL-10 and TNF-α were quantified using commercial sandwich 
enzyme linked immunosorbent assays (ELISAs) of which TNF-α and IL-10 were high 
sensitivity ELISAs (R & D systems, Minneapolis, MN, USA). 
Plasma IL-6, sIL-6R, and CRP were analysed via ‘in-house’ ELISAs (See general 
methods for detail).  All samples were analysed in duplicate and were repeated if the 
CV between duplicates was more than 10 %. The intra-assay CVs for the inflammatory 
proteins are reported in Table 6.3. 
 
6.3.10 RNA extraction and cDNA reaction 
Adipose tissue was lysed for 4 min in 1 ml of TRIzol reagent (GIBCO-BRL, Life 
Technologies, Roskilde, Denmark) using an automated tissue lyser system 
(Tissuelyser II, Qiagen, Hilden, Germany). Following tissue lysis, metal lysis beads 
were removed and the Eppendorf tubes incubated for 10 min at room temperature. At 
this stage 200 µl of chloroform was added to each sample to partition proteins into the 
organic phase and nucleic acids into the aqueos phase. All samples were vortexed for 
~ 20 s before 20 min incubation at room temperature and then spun at 14000 x g for 
20 min at 4 °C. Following the spin phase, 500 µl of clear aqueous phase was 
transferred to a new 1.5 ml Eppendorf tube followed by 500 µl isoproponol. This was 
done in order to aggregate RNA into pellet. After thorough mixing this was incubated 
at room temperature for 30 min and then spun at 14000 x g for 20 min at 4 °C to 
remove alcohol soluble salts. Isopropanol was next removed from each tube leaving 
only the pellet. At this point 1 ml of 70 % ice cold ethanol was added to each tube and 
spun at 14000 x g for 20 min at 4 °C. Ethanol was removed and the pellet allowed to 
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air-dry for 30 min. Once dry the pellet was left to dissolve for 10 min in 30 µl RNase 
free water with occasional agitation.  
 
RNA concentration was assessed by adding 1 µl of sample to a Nanodrop 
spectrophotometer (NanoDrop 2000, Thermo Scientific, Vantaa, Finland). Additionally 
260/280 absorbance ratios were reviewed in order to assess any potential 
contamination (Table 6.2). Any samples not achieving ≥ 1.80 ratios were repeated.  
 
Table 6.2 - Average RNA concentrations across all trials and associated 260/280 
absorbance ratios.  
 
 
After extraction, 1 ng of RNA from each sample was translated into cDNA using a high 
capacity RNA to cDNA kit (Life Technologies, Carlsbad CA, USA). All reactions took 
place in 0.5 ml Eppendorf tubes with 1 x RT+ and 1 x RT- reactions performed on all 
samples in accordance with manufacturer’s instructions. On completion of reaction 
preparation all samples were subjected to thermal cycling which consisted of 1 cycle 
of 60 min at 37 °C, 5 min at 95 °C followed by cooling to 4°C. 
 
 
 
Trial RNA Concentration (ng.µl-1) 260/280 Ratio 
Pre 153.49 1.86 
Post  163.24 1.90 
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6.3.11 Real-time QPCR 
Real-time QPCR was performed on a real-time PCR system (ViiA 7, Life 
Technologies, Carlsbad CA, USA) using Taqman gene expression assays, purchased 
from Applied Biosystems. The following probe sets were used; For cytokines: IL-6 
(Hs00985639_m1); IL6r (Hs01075666_m1), IL-10 (Hs00961622_m1), TNF-α 
(Hs01113624_g1), MCP-1 (Hs00611256_m1), HMOX-1 (Hs01110250_m1); For 
macrophage markers: CD68 (Total macrophages, Hs Hs02836816_g1), MRC-1 (M2 
macrophages, Hs00267207_m1), ITGAX (M1 macrophages, Hs00174217_m1); For 
marker of hypoxia HIF-1α (Hs00153153_m1); and for the house keeping gene, β2-
microglobulin (B2M) (Hs00984230_m1). 
 
Cycle thresholds (CT) values of the B2M housekeeping gene were not significantly 
correlated with changes in physiological parameters and remained stable across 
measurements making it a strong housekeeping gene for analysis of adipose tissue in 
this cohort. 
 
6.3.12 Statistical analysis 
Statistical analyses were carried out using SPSS version 21 (SPSS Inc, an IBM 
company) as described in general methods. Specifically, pre to post differences in 
blood pressure, basal plasma glucose and insulin, glucose and insulin AUC, 
anthropometry, inflammatory proteins and V̇O2peak data were assessed using paired 
sample t-tests. Statistically, paired t-tests did not reveal a difference between 2 
baseline OGTT measures and as such the first of the 2 measurements was accepted 
as baseline. Pre to post changes in gene expression were assessed via paired 
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samples t-test using ∆CT values as described elsewhere (Schmittgen and  Livak  
2008). 
 
The previous chapter highlighted a high degree of variability within OGTT and 
inflammatory parameters. The current chapter aims to look in more detail at individual 
responses in selected parameters. These were analysed and ranked according to 
percentage change. Confidence intervals (95 %) were computed for all of the variables 
in order to provide narrower estimates of true magnitude of change. Following previous 
procedures (Scharhag-Rosenberger et al. 2012; Astorino and Schubert 2014), 
participants were categorised as ‘responders’ if magnitude of percentage change in 
individual response exceeded 1 CV from baseline after accounting for measurement 
error. Non-responders were categorised as individuals improving less than 1 CV 
above baseline.  
 
6.4 Results 
6.4.1 Inflammatory proteins in the circulation 
Circulatory inflammatory protein data are presented in table 6.3. No changes were 
measured for IL-10, TNF-α, CRP, IL-6, sIL-6R or MCP-1. Singularly, HMW adiponectin 
significantly decreased following 6 weeks of HIT training. The coefficient of variation 
for each protein assay is also presented in table 6.3 and reflects variation between 
duplicate samples on a single assay plate. Table 6.4 highlights percentage responder 
types for each proteomic marker with accompanying confidence intervals and ranges. 
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Table 6.3  Inflammatory proteins in plasma pre and post 6 weeks of HIT training. Data are presented as range and (median) 
with delta (∆) change describing the mean post minus pre adaptation. % CV between duplicate samples is 
provided with all analyses. 
 
 
 
 Pre-Training Post-Training  p % CV 
Protein Range (Median) Range (Median) ∆ Change Sig*. ≤ 0.05 Duplicates 
adiponectin (µg.ml-1) 0.3-12.8 (2.4) 0.2-7.6 (1.7) -0.96 0.01* 8.5 
IL-10 (pg.ml-1) 0-1.3 (0.1) 0-0.6 (0.2) -0.06 0.710 5.3 
TNF-α (pg.ml-1) 1.1-5.9 (2.7) 1.5-5.8 (3.1) 0.1 0.458 8.5 
CRP (µg.ml-1) 0-6.3 (1.5) 0-11.3 (1.9) 0.7 0.981 3.9 
IL-6 (pg.ml-1) 1.5-6.9 (2.2) 1.5-12.2 (2.1) 0.45 0.674 8.6 
sIL-6R (ng.ml-1) 0.8-2.4 (1.6) 0.7-2.7 (1.4) -0.06 0.667 6.7 
MCP-1 (pg.ml-1) 100.2-607 (347.4) 193.1-654.6 (307.1) -14.7 0.842 8.4 
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Table 6.4  Percentage representation of participants categorised as responders or non-responders for plasma inflammatory proteomic 
changes following 6 weeks of HIT. Responders were defined as those achieving a favourable ≥ 1CV magnitude of change 
from the mean, with non-responders showing an adverse magnitude of change ≥ 1CV from the mean.  
 
 
Protein Responders (%) Non-Responders (%) Mean Change (%) 95 % CI (%) Range (%) 
IL-6 33 47 10.55  -10.40 - 31.49  -37.22 - 109.82 
sIL-6R 47 27 -1.17  -16.88 - 14.54  -43.74 - 90.35 
CRP 47 53 82.96  -48.36 - 214.29  -156.76 - 800 
adiponectin 6 73 -17.38  -33.91 - -0.85  -50.15 - 85.91 
TNF-α 33 33 9.97  -7.04 - 26.97  -27.31 - -2.37 
IL-10 47 47 55.54  -23.22 - 134.30  -103.12 - 451.03 
MCP1 60 33 9.2  -19.62 - 38.03  -55.07 - 104.70 
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6.4.2 Adipose tissue gene expression  
M2 macrophage expression as determined by MRC-1 expression was significantly 
up regulated following 6 weeks of HIT training (p = 0.001). No significant changes in 
gene expression were detected for HIF-1α (p = 0.135), TNF-α (p = 0.866), CD68 
(Total macrophage marker; p = 0.756), ITGAX (M1 macrophage marker; p = 0.781), 
IL-10 (p = 0.971), IL-6 (p = 0.634), IL6-R (p = 0.838), HMOX-1 (p = 0.694) or CD46 
(Encoding for MCP-1; p = 0.138) (Figure 6.2). Individual responder types are 
highlighted in Table 6.5. 
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Figure 6.2  Graphical representations of fold changes defined by 2-∆∆Ct of all genes following 6 weeks of HIT training. The 2-∆∆CT was 
derived from the equation: [Sample A (CT gene of interest – CT internal control)] – [Sample B (CT gene of interest – CT 
internal control)]. Significant changes from baseline (*) were demonstrated for MRC-1.  
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Table 6.5  Percentage representation of participants categorised as responders or non-responders for gene expression changes 
following 6 weeks of HIT.
Gene Responders (%) Non-Responders (%) 
CD46 27 40 
CD68 47 27 
HIF1-α 33 0 
HMOX-1 20 33 
IL-6 20 20 
IL-6R 27 13 
IL-10 13 20 
ITGAX 47 27 
MRC-1 40 7 
TNF-α 20 20 
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6.4.3 Insulin sensitivity  
After the 6 week HIT intervention there were no significant changes in fasting glucose 
(p = 0.093), fasting insulin (p = 0.401) or the Matsuda insulin sensitivity index (p = 
0.852), nor were there any differences found for the area under the glucose (p = 0.736) 
or insulin (p= 0.719) concentration curves in response to a 2 h OGTT. The glucose 
and insulin responses to the 2 h OGTT before and after training are shown in figure 
4.3.3. Basal insulin showed a mean cohort increase of 14.3 % (12.77 ± 9.42 mU.l-1 to 
14.60 ± 12.44 mU.l-1). A total of 11 % participants were responders for basal insulin 
improvement (95 % CI = -4.04 % - 36.32 %, Range = -58.06 % - 112.21%). Basal 
glucose responses (5.13 ± 4.64 to 5.59 ± 4.93) were less marked demonstrating a 
group mean increase of 9 % (95 % CI = 1.34 % - 13.36 %, Range = -14. 92 % - 29.49 
%). For this parameter 17 % of participants were responders to HIT exercise and 50 
% non-responders. 
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Figure 6.3  Area under the 2 hour a) glucose concentration curve (mmol.l-1) and b) 
insulin concentration curve (mU.l-1). Data points represent mean and 
standard deviation. 
 
With respect to insulin AUC a mean cohort change of 2.86 % was shown following HIT 
(95 % CI = -17.14 % - 22.87 %, Range = -59.29 % - 112.53 %). Data demonstrated 
11 % of participants as responders to training in this parameter with 22 % of 
participants defined as non-responders. A mean change of 2.90 % was shown in 
glucose AUC (95 % CI = -4.48 % - 10.29 %, Range = -19.07 % - 27. 72 %) with 28 % 
responders and no non-responders.  
a) 
b) 
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6.4.4 Body composition, blood pressure and peak oxygen uptake  
After 6 weeks of HIT training there were no changes in body mass (p = 0.658) or BMI 
(p = 0.630). DEXA data (Figure 6.4) showed no changes in tissue or regional fat (%), 
total tissue (g), total lean tissue (g), total fat tissue (g) or bone mineral content (BMC) 
(g) within this cohort (p > 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4  Changes in tissue and regional % fat, total tissue (g), total lean tissue (g), 
total fat tissue (g) and bone mineral content (BMC)(g) as measured by 
DEXA. Data are presented as percentage change (%) and standard 
deviation. 
 
No significant changes in systolic (SBP) (p = 0.173) or diastolic (DBP) (p = 0.460) 
blood pressure were observed following 6 weeks of HIT training. Based on individual 
response criteria 14 % of participants were non-responders to HIT for changes in 
DBP, with no participants being classified as responders. Moreover 14 % of 
individuals were classified as responders for changes in SBP with no participants 
falling into the non-responder criteria. The mean magnitude of change for SBP was -
2.01 % (95 % CI = - 4.64 % – 0.62 %, Range = -11.97 % – 5.98 %). Additionally the 
  Tissue Fat (g)    Regional Fat (%)   Total Tissue (g)      Fat (g)           Lean Tissue (g)           BMC (g) 
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mean % change for DBP was 1.91 % (95 % CI = -2.40 % - 6.22 %, Range = -11.39 
% – 18.31 %). 
  
V̇O2peak significantly improved following training in absolute and relative terms (P = < 
0.01). Mean % change in relative V̇O2peak equated to 14.1 % (95 % CI = 9.1 % - 19.1 
%, Range = -5.0 % – 36.4 %). Using relative values, 83 % of participants were 
classified as responders with 17 % classified as non-responders (Figure 6.5).  
 
 
 
 
 
 
Figure 6.5  Changes in a) relative and b) absolute V̇O2peak following 6 weeks of HIT 
training. Data are expressed as mean and standard deviation.
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Data revealed that self-reported dietary intake significantly decreased following 6 
weeks of HIT training (p = 0.01) (Figure 6.6). Additionally total energy expenditure 
(omitting the formal exercise period) of the full cohort, as estimated by the Acti-
heart device, did not change as a consequence of the exercise trial, before, during 
or after the intervention (p > 0.05) (Figure 6.7) 
 
 
 
 
 
 
 
 
  
 
 
Figure 6.6  Changes in self-reported dietary intake. Data represent a comparison 
between pre intervention and week 6 of training. Data are presented 
as mean energy intake in kilojoules (kJ) and standard deviation. 
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Figure 6.7  Changes in estimated total energy expenditure as measured by Acti-
heart. Data represent a comparison between 2 x pre-exercise 
measurements, a mid-training measurement and a 1 week post-
intervention measurement. Data are presented as mean energy 
expenditure per day in kilojoules (kJ.d-1) and standard deviation. 
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6.5 Discussion 
The primary aim of this study was to profile the effectiveness of a low volume HIT 
protocol (Larsen et al. 2014), for improving aerobic capacity, glucose control, and 
inflammatory profile in an obese “at risk” cohort with particular focus on adipose 
tissue inflammatory gene expression. This study has demonstrated that 6 weeks 
of HIT training was successful in improving peak aerobic capacity and 
successfully up-regulated expression of genes related to anti-inflammatory 
responses in adipose tissue. Exercise however did not improve glucose control 
or markers of inflammation. 
 
The present study is the first to demonstrate significant up-regulation in the M2 
macrophage marker MRC-1, following low volume HIT training. 
Although there is complexity around the macrophage classification and the 
associated inflammatory response (Martinez and Gordon 2014), classically the 
M1 macrophage phenotype is induced by inflammatory factors such as TNF-α 
and produces pro-inflammatory cytokines, with the M2 phenotype induced by 
factors such as IL-4 and IL-10 to produce anti-inflammatory cytokines (Sulahian 
et al. 2000; Gratchev et al. 2001; Martinez, Helming and Gordon 2009; Dalmas, 
Clement and Guerre-Millo 2011). Increases in M2 macrophage phenotypes have 
been shown in morbidly obese patients who lost 22 kg in 3 months, following 
Roux-en-Y gastric bypass (Cancello et al. 2005). Also obese mice fed high fat 
diets in combination with a 16 week endurance training programme demonstrated 
significant up-regulation of genes associated with M2 macrophages (Kawanishi 
et al. 2010). In the current study, data suggests no change in body fat, which 
might suggest that exercise alone can cause the gene expression change.  
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This study did not find any changes in inflammatory mediators, therefore although 
not measured here, the possible pathway for the up-regulation of the M2 
macrophage phenotype may in part be explained by glucocorticoid hormones, 
which will have been released following the high intensity exercise (Deuster et al. 
1998). Following secretion from the adrenal glands, glucocorticoids are 
metabolised by cellular enzymes in macrophages. Active glucocorticoids are 
lipophilic and diffuse through the membrane to bind to glucocorticoid receptor 
alpha (GCR-α) leading to nuclear translocation of the complex. The GCR-α binds 
to DNA directly to promote M2 gene expression and repress M1 gene 
transcription (Varga et al. 2008) either directly or indirectly through transcription 
factors such as NF-κB (Martinez and Gordon 2014).  
 
Despite significant changes in macrophage polarisation, the current study saw no 
other changes in inflammatory markers other than plasma adiponectin, which 
significantly decreased. Data is variable as to the response of adiponectin to 
exercise training. There is clear evidence to suggest that adiponectin levels are 
inversely correlated with BMI (Arita et al. 1999; Weyer et al. 2001; Bruun et al. 
2003; Kern et al. 2003; Ryan et al. 2003; Vilarrasa et al. 2005; Bluher et al. 2006), 
however a review by Simpson and Singh (2008) demonstrated that only 3 from 8 
randomised control trials involving exercise training resulted in increased levels 
of plasma adiponectin and data suggests that in order to achieve increases in 
adiponectin, dietary restriction with a 10 % weight loss is required (Madsen et al. 
2008). What should be made clear is that these studies fail to significantly isolate 
adiponectin isoforms and as such conclusions are based on the measurement of 
total adiponectin. 
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There are some studies which have indicated increases in total adiponectin with 
additional evidence to suggest that 1 year of high intensity exercise causes an 
increase in adiponectin independent of weight loss (Balducci et al. 2010). 
However in agreement with the current findings, Christiansen and colleagues 
(2010b) showed a small non-significant decrease in plasma adiponectin following 
3 months of exercise training, yet in diet and diet plus exercise groups levels were 
increased. Leggate and colleagues (2012) also demonstrated a significant 
reduction in HMW adiponectin following 2 weeks of HIT training in an obese 
cohort. Intriguingly the current study data suggests a significant reduction in 
calorie intake of ~ 30 %, but this did not change body composition.  Taking into 
account average habitual energy expenditure data (Figure 6.7) and the estimation 
of energy expended during a typical training session (≤ 1000 kJ) as well as no 
change in body mass data (Table 6.1) it may suggest that the participants under-
reported within their diet diaries and as such the energy deficit may not have been 
as marked as that reported.  
 
There is evidence to suggest that it is the ratio of HMW adiponectin to total 
adiponectin which shows the strongest correlation with insulin sensitivity in 
humans and not necessarily total adiponectin or individual isoforms (Pajvani et al. 
2004; Lara-Castro et al. 2006).  Neither low molecular weight (LMW) nor total 
adiponectin were measured in the current study but it is tempting to speculate that 
all adiponectin isoforms were decreased following exercise, with decreases in 
HMW adiponectin showing the least decrement and thus increasing the ratio in 
favour of the HMW isoform. If this were the case and given data to suggest a role 
for HMW adiponectin in the modulation of human monocytes and macrophages 
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toward an anti-inflammatory phenotype (Wolf et al. 2004) may explain why 
significant decreases in HMW adiponectin were found in the current study 
independent of changes in body mass and with maintenance of positive 
macrophage responses. Future work should aim to measure high and low 
molecular weights of adiponectin as well as total levels in order to gain a more 
complete conclusion based on isoform ratios. This is particularly important given 
that the findings in the current study are not isolated (Christiansen et al. 2010b; 
Leggate et al. 2012). 
 
Data concerning systemic and adipose tissue inflammation following HIT training 
is limited with a majority of previous exercise models incorporating higher volume 
continuous-moderate exercise. Leggate et al (2012) provide the only work to date 
evaluating systemic and adipose inflammation after HIT training. This protocol 
although referred to as the umbrella term HIT falls into the category of AIT using 
the previously reported protocol (Talanian et al. 2007). Leggate et al (2012) 
demonstrated a significant reduction in plasma sIL-6R, MCP-1 and adiponectin. 
Within adipose tissue IL-6 was reduced with no changes detected in ICAM-1 with 
TNF-α, MCP-1 and IL-10 undetectable within the adipose tissue. These data 
(Leggate et al. 2012) show some similarity with those in the current study with 
regards lack of change in TNF-α and MCP-1 in circulation.  
 
Justification for the differing responses between the findings of Leggate and 
colleagues (2012) and those in the current study with regards to plasma and 
adipose inflammatory markers is most likely attributed to the volume of exercise 
incorporated within the programme. Leggate and colleagues (2012) utilised ~ 240 
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min of high intensity efforts over 2 weeks compared to the 90 min over 6 weeks 
in the current study. 
 
Polak et al. (2006) demonstrated similar results to those of the current study using 
an obese cohort. This group (Polak et al. 2006) showed no change in plasma 
adiponectin, TNF-α or IL-6 following 12 weeks of aerobic exercise.  Despite a high 
weekly volume of 225 min, based on the aforementioned theory the exercise 
intensity (50 % V̇O2max) used by Polak et al (2006) may not have been high 
enough to induce beneficial changes. Similar findings were demonstrated by 
Leick et al (2007) who saw no changes in adipose tissue mRNA for adiponectin, 
leptin, IL-6 or TNF-α following 8 weeks of higher intensity exercise (70 % V̇O2max) 
within an obese cohort and detected no changes in circulatory or adipose tissue 
IL-18. This leads to the proposal that 90 min of high intensity effort across 6 weeks 
is insufficient in inducing positive changes in inflammatory profile, with a more 
likely weekly volume ≥ 120 min being required with a minimum intensity of 85 % 
V̇O2max  
 
There is still a need however to ascertain the true volume – intensity intercept 
required to induce positive changes in inflammatory profile with HIT exercise. This 
chapter makes clear that a total of 90 min of high intensity effort utilised over 6 
weeks is not sufficient in improving most markers of inflammation.  
 
Inflammation in both plasma and adipose tissue has been linked with insulin 
resistance and T2DM. (Dandonda, Aljada and Bandyopadhyay 2004; Schoelson, 
Lee and Goldfine 2006). Previous work suggests that HIT may result in significant 
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improvements in insulin resistance however results are varied and could relate to 
the large variety of training protocols being characterised under the one umbrella 
of HIT. Significant improvements in glucose control have been demonstrated in 
as little as 2 weeks following SIT based exercise in healthy (Babraj et al. 2009; 
Richards et al. 2010) and obese (Whyte et al. 2010) populations. Similar 
improvements have been demonstrated in the same time period following sub-
maximal HIT in physically inactive (Hood et al. 2011) and T2DM (Little et al. 2011) 
cohorts and with a similar RE-HIT protocol over a 6 week period Metcalfe et al 
(2011) have shown an improvement in insulin sensitivity of 28 %. Recently 
Shepherd and colleagues demonstrated that 6 weeks of SIT exercise reduced 
glucose AUC by 17 % and insulin AUC by 33 % with an overall increase in insulin 
sensitivity of 56 % in a physically inactive cohort.  When comparing the cohort in 
the current chapter to those in the aforementioned works assessing glucose 
control it becomes clear that baseline V̇O2peak values are approximately 36 % 
lower compared to those previously reported (Kessler et al. 2012). This gives rise 
to the suggestion that a minimal aerobic capacity must first be achieved before 
improvements in glucose control occur. In agreement with the data in the current 
chapter and in line with this theory, Gillen and colleagues (2013) demonstrated 
that 6 weeks of HIT training identical to that described previously (Little et al. 
2011), was not sufficient in improving insulin sensitivity in overweight women, who 
all demonstrated an average basal V̇O2peak of 28 ml.kg-1.min-1.  It may be 
suggested that a V̇O2peak in the range of 30-35 ml.kg-1.min-1 must first be acquired 
in order for insulin sensitivity to improve, which may be an indirect reflection of 
changes in mitochondrial function (Weibel, Taylor and Huppeter 1991). From an 
individual response perspective data from the HERITAGE family study (Boule et 
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al. 2005), currently the largest (n=600) investigation of glucose homeostasis 
following exercise (20 weeks, 3 x week cycling 55 % - 76 % V̇O2max) demonstrated 
that 42 % of their cohort demonstrated no change or impairment in insulin 
sensitivity following exercise which is in comparison with 65 % in the current 
cohort, with HERITAGE (Boule et al. 2005) demonstrating that 54 % of individuals 
showed impairment in glucose AUC, in comparison to the 65 % demonstrated in 
the current cohort. This suggests that in the current sample, albeit large for a 
tissue biopsy study, was a sample weighted towards non-responders and those 
who were impaired. The reason for these non or adverse responses remain 
unclear however they are likely to be driven by pre-disposed genetic factors which 
are currently the subject of intensive investigation within the field.  Although not 
directly comparable, these data demonstrate that negative responses in glucose 
homeostasis are not rare occurrences following exercise and that in many studies 
these responses may be masked by highly positive responders who dominate 
group means. These data further highlight the importance of reporting individual 
responses within data sets to gain a true reflection of exercise responses.  
 
When looking in more detail at the current cohort and in contrast to 
aforementioned works (Babraj et al. 2009; Richards et al. 2010; Whyte et al. 2010) 
basal insulin levels were deemed elevated (Belfiore, Ianello and Volpicelli 1998). 
Mean basal insulin levels in the current cohort rose by 14 %, which may initially 
suggest that the exercise intervention may have negatively impacted upon insulin 
sensitivity. This response is difficult to justify given the volume of previously 
reported positive outcomes associated with this exercise modality, however as 
mentioned above may relate to individual responses driving the group mean and 
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hence why individual responses have been reported in this chapter. From those 
determined as non-responders to basal insulin change, 1 participant showed 
worsened basal insulin profile showing an adverse 112 % change which may 
partly explain the overall poor response within the cohort. Yet when this individual 
is removed from the cohort the median % decrement is only improved by 1.28 % 
(19.93 % decrement vs. 18.65 %) highlighting that this one particularly poor 
response is more marked than others, however is certainly not an isolated event. 
 
One speculative theory for the worsened glucose control arises from impaired 
mitochondrial uptake and oxidation of fatty acids (Morino et al. 2006; Ruderman 
et al. 1999). A theory suggests that muscle insulin resistance arises from impaired 
mitochondrial uptake and oxidation of fatty acids (Ruderman et al. 2006; Morino 
et al. 2006), which has been specifically associated with obesity and T2DM 
(Kelley et al. 2002; Hojlund et al. 2008). Specifically this model suggests that long-
chain acyl CoAs (LC-CoAs) derived from circulating lipids or intra-muscular TAG 
are diverted away from carnitine palmityltransferase 1 (CPT 1) and are instead 
preferentially partitioned towards the synthesis of signalling intermediates such 
as diacylglycerol (DAG) and ceramide. The accumulation of these and other lipid 
molecules is thought to engage stress activated serine kinases that interfere with 
insulin transduction (Yu et al. 2002; Holland et al. 2007). In the context of the 
current study it may be theorised that if lipolysis is high immediately after HIT, this 
may provide the catalyst for FFAs to overload the obese dysfunctional 
mitochondria. The subsequent incomplete fatty acid oxidation may contribute to 
downstream skeletal muscle insulin resistance defined in the current study by 
elevations in basal insulin. These findings are not isolated and are replicated in a 
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sub-population within the STRRIDE studies (Slentz et al. 2004) which in part 
investigated exercise intensities and durations within >100 obese (un-published 
data, Kraus et al. 2014). More work is required in order to ascertain the true 
contribution of this speculative mechanism. 
 
Compelling evidence has shown that V̇O2max is a strong and independent 
predictor of all cause and cardiovascular disease mortality (Carnethon et al. 2003; 
Chase et al. 2009; Kodama et al. 2009; Lee et al. 2010). Due to a perceived 
nervousness within physicians to provide therapies that improve V̇O2max, the 
importance of aerobic capacity is often overlooked from a clinical perspective 
compared with other risk factors such as obesity and insulin resistance. The 
current study demonstrated a 13 % improvement in V̇O2peak following 6 weeks of 
HIT training. Although not demonstrate in this thesis, previous work has 
demonstrated significant improvements in V̇O2max following as little as 2 weeks of 
HIT training (Rodas et al. 2000; Talanian et al. 2007; Whyte et al. 2010; Leggate 
et al. 2012). Talanian and colleagues (2007) demonstrated that following 7 HIT 
sessions V̇O2peak was increased in healthy women. This followed a HIT protocol 
consisting of 10 repetitions of 4 min at 85 % V̇O2peak separated by 2 min recovery. 
Later Whyte et al (2010) demonstrated significant improvements in V̇O2max 
following 2 weeks of SIT within an obese population. With closer comparison to 
the current study, longer duration training studies (6 – 8 weeks) utilising HIT and 
SIT have also shown similar positive improvements in aerobic capacity 
(Burgomaster et al. 2008; Shepherd et al. 2013; Larsen et al. 2014). Shepherd 
and colleagues (2013) subjected healthy young participants to 6 weeks of classic 
SIT training 3 x per week. Results demonstrated a significant 7 % increase in 
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V̇O2max following training, with similar improvements demonstrated following 6 
weeks of sub-maximal HIT training (Larsen et al. 2014). These data would 
suggest that the protocol in the current study was more successful in improving 
peak aerobic capacity compared to an arguably more demanding and intense SIT 
protocol.  
 
The relative contributions of aerobic capacity and fat loss to overall morbidity and 
mortality are still unclear (Lavie et al. 2014). This is in part highlighted by the 
obesity paradox proposed by Stephen Blair, demonstrating that lean low fitness 
individuals were at 5.6-fold higher risk of death than obese men with strong 
aerobic fitness. It is likely that aerobic capacity may provide the strongest 
contribution to health however changes in body adiposity must not be disregarded 
given its importance as an endocrine organ (Trayhurn and Beattie 2001). 
 
Low volume high intensity interval training has previously been described as a 
time-effective strategy for improvement in body fat in overweight and obese 
individuals (Tremblay et al. 1994; Mourier et al. 1997; Warburton et al. 2005; 
Schjerve et al. 2008; Tjonna et al. 2008; Trapp et al. 2008; Tjonna et al. 2009; 
Wallman et al. 2009; Whyte et al. 2010; MacPherson et al. 2011; Heydari et al. 
2012). However data from the current study demonstrates that no changes in 
body composition occurred as a consequence of HIT training.  
 
Previous significant body composition changes associated with short duration (2 
weeks) SIT and AIT exercise (Whyte et al. 2010; Leggate et al. 2012) have been 
described by waist circumference measures which can be associated with high 
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levels of measurement error (Ulijazek and Kerr 1999) and could explain the 
discrepancy with the findings in the current study. Despite Leggate and 
colleagues (2012) utilising 40 min of high intensity effort, a low total training 
volume (2 weeks) makes it unlikely to have contributed significantly to fat loss. 
From the analysis presented throughout this thesis, the suggestion arises that 
higher accumulated training volumes (> 6 weeks) may be required as opposed to 
long duration (> 40 min) HIT exercise sessions over a short-term (2 week) period. 
 
Shepherd and colleagues (2013) indicated that following 6 weeks of SIT training 
participants failed to decrease fat mass and with a similar protocol to the current 
study, Keating and colleagues (2014) showed that after 12 weeks of training 
consisting of up to 6 x 1 min bouts at 120 % V̇O2peak with 2 min recovery periods, 
3 x per week, there were no improvements in total body mass, lean mass or any 
measures of fat mass. In Keating’s study a continuous moderate training arm over 
the same duration and frequency but consisting of 30 min – 45 min at 50 % - 65 
% V̇O2peak demonstrated significant improvements in the aforementioned 
parameters both above baseline levels and in comparison to changes associated 
to HIT suggesting that energy expenditure associated with increased training 
volume may be critical in order to promote changes in body fat.  
 
Having demonstrated high accumulated training volume, Heydari et al. (2012) 
demonstrated significant reductions in body fat within an obese cohort after 12 
weeks of HIT. The training consisted of 8 s bouts at 90 % HRpeak with 12 s 
recovery periods. The stark differences between these data (Heydari et al. 2012) 
and those presented in the current study are again possibly explained by the 
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training volume and length. Heydari and colleagues (2012) took measurements 
of body composition at 3 week intervals throughout the study. The authors report 
that at weeks 3 and 6 no changes in body composition were reported, whereas at 
week 9 changes in body composition became significant. It is likely that total 
exercise energy expenditure in their study would have been relatively low, an 
assumption made against the protocol utilised in this current study and that 
profiled previously (Kelly et al. 2013). Despite being low the volume of high 
intensity work was approximately 33 % higher in the Heydari et al. (2012) protocol 
compared with Keating et al. (2014). Using an extended training period Keating 
and colleagues (2014) failed to show any changes in body fat following 12 weeks 
of exercise, utilising a highly similar protocol to that of the current study. Current 
data and previous literature suggesting that 8 – 24 week HIT studies reduce body 
fat (Tremblay et al. 1994; Mourier et al. 1997; Bodouou et al. 2003; Trapp et al. 
2008; Dunn et al. 2009; TjØnna et al. 2009; Heydari et al. 2012) gives rise to the 
suggestion that had the current study been extended beyond 6 weeks to a 15 
week duration, then total energy expenditure may have accumulatively provided 
stimulus for significant body composition changes.  
 
From the data in the current study and that described previously it is suggested 
that changes in body composition are explained by differences in accumulated 
training volume. No clear statements currently can be made as to whether 
significant changes are dominated by alterations in visceral as opposed to 
subcutaneous compartments following HIT training given the lack of well 
controlled data. More work utilising more sensitivity measures such as MRI are 
required to explore this paradigm. 
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In summary this chapter has demonstrated that 6 weeks of HIT based training in 
an obese cohort, equating to ~ 90 min of high intensity exercise was successful 
in mediating anti-inflammatory effects within adipose tissue. Additionally, 
significant improvements in maximal aerobic capacity were observed. These 
findings suggest that this specific HIT intervention may be successful in improving 
markers of cardio-metabolic health with changes likely to be more profound if 
extended beyond a 6 week period. Future work should aim to use this model 
within a larger cohort and modify volume and intensity, generating a dose 
response output and thus elucidating the optimal intensity – duration intercept. 
Equally, this HIT protocol should be compared against an energy matched 
continuous protocol in order to ascertain the true contribution of the intermittent, 
high-intensity modality to improve cardio-metabolic health. 
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7CHAPTER 7 
 
 
 
GENERAL DISCUSSION 
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7.1 General discussion 
Glucose control following acute exercise and exercise training is highly variable 
in nature. Data from the current thesis (chapter 6) described 2 clear populations 
or phenotypes, with individuals showing strong improvements in insulin sensitivity 
or indeed an adverse or non-response. Using a simple statistical model it has 
been possible to show here that group mean changes could be driven by a large 
ratio of adverse responses. The HERITAGE family study (Boule et al. 2005), 
demonstrated that 42 % of participants showed no change or impairment in insulin 
sensitivity following exercise training. It is reasonable to suggest that cohorts 
presented in the current thesis were hugely varied and those with a non-
responsive phenotype dominated the group mean.  
 
With this in mind it is not simple to describe HIT as being a positive or negative 
health intervention based purely on the group statistical output. Contrasting to the 
data in this thesis significant improvements in glucose control have been 
demonstrated in as little as 2 weeks following SIT based exercise in healthy 
(Babraj et al. 2009; Richards et al. 2010) and obese (Whyte et al. 2010) 
populations. Similar improvements have been demonstrated in the same time 
period following HIT in sedentary (Hood et al. 2011) and T2DM (Little et al. 2011) 
cohorts with improvements also evident after longer-term interventions (Metcalfe 
et al. 2011; Moreira et al. 2008; Nybo et al. 2010; Shepherd et al. 2013; Tjonna et 
al. 2008, 2009). It is proposed here that in those with ‘responsive’ phenotypes, 
HIT training proves to be a useful methodology for improving insulin sensitivity 
however in the ‘adverse’ phenotypes such as those described here and 
elsewhere (Boule et al. 2005), this exercise may actually be detrimental to 
metabolic health.  Moreover the majority of participants throughout this thesis 
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were within normal healthy insulin and glucose ranges prior to training. It is likely 
that individuals with clinically elevated metabolic parameters may stand to 
improve most (if of the responsive phenotype). Future work should aim to utilise 
the protocols described here within a cohort of individuals presenting with 
impaired glucose control. 
 
In continuation from the above and owing to a strong relationship, it is clear that 
improved glucose control may be a reflection of a reduced inflammatory profile 
(Dandonda, Aljada and Bandyopadhyay. 2004; Schoelson, Lee and Goldfine. 
2006). This thesis has demonstrated that HIT training may directly impact upon 
the inflammatory status of adipose tissue (chapter 6).  It has been demonstrated 
here for the first time that a modified low volume HIT protocol lasting < 15 min 
(Larsen et al. 2014) up-regulated the expression of M2 phenotype macrophages 
in adipose tissue. Findings imply an increased potential for the body to produce a 
localised anti-inflammatory environment independent of significant changes in 
any other inflammatory mediators (plasma or adipose) or indeed body fat. 
 
Classically, the inflammatory response is partly described by the production and 
release of inflammatory mediators via macrophages. Macrophages although 
probably of mixed phenotypes do show 2 distinct lineages, which are pro-
inflammatory (M1) and anti-inflammatory (M2). The M2 macrophage phenotype 
has been shown to produce and release anti-inflammatory mediators such as IL-
4, IL-10 and IL-13 (Martinez and Gordon 2014). Macrophages demonstrate high 
levels of plasticity and can switch between phenotypes when exposed to certain 
stimuli. 
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Little human data exists as to the role of exercise in the phenotype switching of 
macrophages with some evidence describing this response following surgically 
induced weight loss (Cancello et al. 2005) and continuous exercise in the rat 
(Kawanishi et al. 2010). Given the lack of changes in any other inflammatory 
mediator a possible pathway for the up-regulation of the M2 macrophage 
phenotype may be explained by glucocorticoid hormones, which will have been 
released following high intensity exercise (Beaudry, Riddle 2012; Deuster et al. 
1998). Glucocorticoids are released following exercise at intensities ≥ 80 % 
V̇O2max (Beaudry, Riddle 2012; Deuster et al 1998; Slentz et al. 2009). Once 
bound to the glucocorticoid receptor, the glucocorticoids promote M2 macrophage 
gene expression via direct binding to DNA.  
 
If true, then increased exposure to elevated levels of glucocorticoids as well as 
individual mitochondrial function may partly explicate the detrimental glycaemic 
responses in non or adverse responders. The proposed intermittent 
glucocorticoid exposure via HIT training (Van raalte et al. 2011) may have 
provided a catalyst for FFAs to overload the obese potentially dysfunctional 
mitochondria in obese individuals (Ruderman et al. 2006; Morino et al. 2006). The 
subsequent incomplete fatty acid oxidation may contribute to downstream skeletal 
muscle insulin resistance (Morino et al. 2006; Ruderman et al. 2006; Slentz et al. 
2009). 
 
Other than macrophage changes in adipose tissue, this thesis demonstrated no 
changes in any other inflammatory mediators following short (2 weeks) or medium 
term (6 weeks) training. Exclusively, Leggate et al (2012) provided evidence for 
reduced inflammation after HIT training. Using a previously reported protocol 
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(Talanian et al. 2007) this group (Leggate et al. 2012) demonstrated a significant 
reduction in plasma sIL-6R, MCP-1 and in agreement with the current findings 
saw no change in TNF-α. Given that training intensities (~ 85 % V̇O2max) in this 
thesis are comparable to that used previously (Leggate et al. 2012) differences 
between findings may be attributed to total training volume.  The 60 min and 90 
min of high intensity effort utilised in chapters 5 and 6 respectively were 
insufficient in inducing positive changes in inflammatory profiles. Data suggest 
that when restricted to short training periods (2 weeks) it is likely that an AIT 
protocol is required in order to induce significant whole-body inflammatory 
changes as described by Leggate and colleagues (2012). If a longer training 
period is afforded then HIT training protocols may be sufficient to reduce 
inflammatory profile as long as ~ 120 min of high intensity effort is achieved per 
week. Based on this theory had the training periods in chapters 5 and 6 been 
extended to ~ 8 weeks then speculatively, changes in inflammatory profile may 
have been detected probably due to higher accumulative net energy 
expenditures. 
 
The above discussions give rise to some key considerations. Firstly, this 
highlights the importance of identifying individual response phenotypes prior to 
exercise prescription to ensure that frequency, intensity and duration is suitably 
tailored. Secondly it is essential that large cohort data is contextualised and 
interrogated as individual responses, as group means may not describe a truly 
meaningful physiological response. Further invasive studies should be employed 
to investigate the potential adverse response of some individuals following HIT 
training. 
 
 142 
 
The obese cohorts within this thesis demonstrated a comparatively low basal 
V̇O2max when compared with previous work (Kessler et al. 2012). Since skeletal 
muscle V̇O2max is a function of interaction between oxygen supply and 
mitochondrial oxidative capacity (Hepple et al. 2002) it may suggest that those 
with the lowest V̇O2max may have the worst mitochondrial function. Equally given 
the lack of change in glucose control following HIT it may give rise to the 
suggestion that in order for glucose control to improve, V̇O2max (and thus 
mitochondrial oxidative capacity) must first reach a minimal threshold to cope with 
the increased metabolic demand associated with HIT training.  Based on the data 
presented here and within previous investigations it is suggested that a basal 
V̇O2max in the range of 30-35 ml.kg.min-1 may indirectly reflect the sufficient 
mitochondrial capacity required to cope with increased metabolic demand 
associated with HIT training.   
 
Future work utilising HIT type protocols should aim to address markers of 
mitochondrial capacity before, during and after training. With concomitant 
frequent V̇O2max measurements the relationship between aerobic capacity and 
mitochondrial capacity may be more extensively explored. This may provide data 
on the usefulness of basal V̇O2max as a predictor of mitochondrial capacity. 
 
V̇O2max may act as a strong surrogate measure for other metabolic processes 
adding to the already established value of this measurement parameter in the 
prediction of all-cause morbidity and mortality (Carnethon et al. 2003; Chase et 
al. 2009; Kodama et al. 2009; Lee et al. 2010). Overwhelming evidence 
demonstrates that SIT, HIT and AIT based exercise is capable of inducing 
improvements in aerobic capacity (Burgomaster et al. 2008; Larsen et al. 2014; 
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Leggate et al. 2012; Macpherson et al. 2011; Moholdt et al. 2009; Nybo et al. 
2010; Rodas et al. 2000; Rognmo et al. 2004; Schjerve et al. 2008; Shepherd et 
al. 2013; Talanian et al. 2007; Tjonna et al. 2008, 2009; Wallman et al. 2009; 
Warburton et al. 2005; Whyte et al. 2010; Wisloff et al. 2007). Despite 
aforementioned findings, chapter 5 failed to detect any changes in V̇O2max.  
 
Original data relating to the protocol used in Chapter 5 (Hood et al. 2011; Little et 
al. 2011) failed to report changes in aerobic capacity making it impossible to make 
direct comparisons. Data within chapter 6 are in agreement with original data 
(Larsen et al. 2014) having demonstrated a significant improvement in aerobic 
capacity after 6 weeks of training. These data give rise to an important 
observation in that total exercise volume (i.e. accumulated minutes spent in high 
intensity bouts) may be a critical factor for improving aerobic capacity when 
utilising HIT based training set at sub-maximal V̇O2 intensities (80 % - 90 % 
V̇O2max). Total accumulated time spent at high intensities within chapter 5 equated 
to 60 min whereas accumulated time at high intensities within chapter 6 equated 
90 min. Despite a 50 % lower weekly training volume in chapter 6 compared with 
chapter 5, the larger total accumulated training volume in chapter 6 provided 
stimulus for a stronger improvement in aerobic capacity.  
Speculatively, had the protocol used within chapter 5 (Little et al. 2011) been 
extended from 2 to 6 weeks it is possible that this protocol would have 
demonstrated the largest improvement in aerobic capacity. This suggests that in 
order to independently increase aerobic capacity, a sub-maximal low volume HIT 
protocol must ensure that participants spend > 60 min accumulated time at high 
intensities.  
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Data specifically describing changes in fat mass following low volume HIT, via 
methods such as DEXA or MRI are sparse, with data to suggest no changes in 
body fat following a HIT protocol identical to that in chapter 6 (Larsen et al. 2014). 
To date only in-direct measures of adipose changes have been taken following 
short-term (2 week) interventions (Leggate et al. 2012; Whyte et al. 2010). 
Although waist circumference has been correlated highly with visceral fat, the 
measurement error involved does not allow for these data to be deemed truly 
reliable. Even with the limited data available evidence suggests that short to 
medium term (2 - 6 weeks) HIT type interventions result in negligible body mass 
changes with only longer term higher volume protocols reporting meaningful 
changes after training (Bodou et al. 2003; Dunn et al. 2009; Heydari et al. 2012; 
Mourier et al. 1997; Tjonna et al. 2009; Trapp et al. 2008; Tremblay et al. 1994). 
It may be fair to suggest that HIT type training in association with increased 
energy restriction may give rise to more marked responses. This point highlights 
the unreliability of self-report diet data. Chapter 6 demonstrated a significant 
reduction in estimated self-reported energy intake however no changes in fat 
mass occurred suggesting under-reporting of caloric intake. Studies providing 
long-term dietary support and monitoring are required to definitively answer this 
question. 
 
7.2 Conclusions  
In conclusion, this thesis has demonstrated that HIT training within an obese 
cohort can significantly augment maximal aerobic capacity however from the data 
presented here it would suggest that accumulated time at high intensities may be 
critical for improving aerobic capacity in a time-efficient manner. It is suggested 
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that ~ 60 min - 90 min over a 6 week period is required when training at  ~ 85 % 
V̇O2max. 
 
For the first time it has been shown that the expression of anti-inflammatory 
macrophage phenotypes are up regulated in subcutaneous adipose tissue 
following HIT training. The true mechanisms for this up regulation are unclear 
however may relate to glucocorticoid release, with this hypothesis warranting 
further investigation. No other changes in inflammatory mediators were detected 
leading to the conclusion that training volume must be increased ≥ 120 min per 
week if a training load of ~ 85 % V̇O2max is utilised over a 6 week period. Future 
work should profile how training volume can be reduced in line with increasing 
intensity. 
 
Glucose responses to HIT training are highly varied and as such further work is 
warranted to repeat experiments similar to those described in this thesis utilising 
much larger cohort numbers. Given the highly diverse training responses 
recommendations cannot yet be made for improving this parameter although it 
may be proposed that response phenotypes do benefit from HIT exercise. 
 
Finally, the evidence presented throughout this thesis suggests that HIT training, 
within the methodological parameters described here, is not a beneficial strategy 
for inducing fat loss over short to medium terms (2-6 weeks). In order for fat loss 
to occur, HIT protocols must be extended in nature giving rise to the supposition 
that total or net energy expenditure is the critical determinant of fat loss and not 
high acute exercise energy expenditure. 
 
 146 
 
It is the opinion of this author that HIT may provide a supplementary training 
stimulus, which should be built in to a more varied and extended training 
programme for obese individuals. This thesis highlights foremost the complexities 
of exercise prescription within pre-clinical cohorts and gives some insight into the 
future of exercise prescription. Data here provide a positive contribution to the 
evolving field of personalised exercise medicine.   
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8APPENDIX 1 
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Table A – A Summary of trials utilising HIT type training interventions 
                   
 
  
   
 
 
 
 
 
 
 
 
 
 
 Abbreviations: BMI (body mass index); WC (waist circumference); WHR (waist:hip ratio);  %BF (percentage of body fat); LBM (Lean body mass); AUC (area under 
the curve); wk (week); s (seconds); min (minutes) -  The symbol (+) denotes increases and (-) decreases in any given parameter. V̇O
2max
 is reported as % 
improvement, with (0%) denoting no change reported within text without supporting figures.  
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